introvivo reduces the amount of the virus in patients with hepatitis c infection . incivo is used to treat adults , adolescents and children from 1865 years of age with peginterferon alfa , ribavirin and telaprevir . it belongs to a class of medicines called ns3 - 4a protease inhibitors . if you have been previously treated with a type of hepatitis c virus , you will not be able to receive incivo unless you have previously received an interferon - based regimen .
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking incivo if : - you are taking peginterferon alfa or ribavirin . your doctor may need to adjust the dose of incivo or theirraindications ( e . g . pregnancy precautions ). incivo should not be used in combination with any other medicines that may cause severe side effects . 56 - you have taken the medicine alfuzosin for symptoms of an enlarged prostate
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen for you . the recommended dose regimen is 3 mg , 6 mg , 2 mg , 8 mg , or 6 mg twice a day . if you have both hepatitis c virus infection and human immunodeficiency virus infection , your doctor may prescribe efavirenz ( see " other medicines and incivo " in section 6 ). if you take more incivo than you should if you accidentally take too many tablets , or if someone else accidentally takes your tablets ,
like all medicines , this medicine can cause side effects , although not everybody gets them . rash if you get an itchy skin rash , stop using incivo and seek medical help immediately . the rash may spread to other areas . other symptoms of a severe skin reaction tell your doctor or nurse immediately if you develop a skin rash . if your rash does not go away or other symptoms are not listed , you may develop a rash . fever , tiredness , swelling of the face and swelling of lymph glands , a wide - spread rash with peeling skin , fever , flu - like symptoms , painful skin blisters or blisters in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicine does not require any special temperature storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture .
what incivo contains - the active substance in incivo is telaprevir . each tablet contains 375 mg of teleprevir ( as besilate ). - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose ( e460i ), silica colloidal an hydrous , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172
the active substance of zinbryta is daclizumab beta , a monoclonal antibody ( a type of protein that recognises and attaches to a specific target substance in the body ). what it is used for your doctor or nurse knows how to use it and why it has been prescribed for you . how it works in patients with multiple sclerosis , therapy is usually started as two ms treatment followed by other treatments . inflammation destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms
you must not be given zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have liver problems . your doctor may need to adjust your dose . you have ever had or might now have any other autoimmune disorders . you are taking any other medicines , including herbal supplements . this is because these may increase the risk of liver side effects . you should not take any of these medicines while you are being given
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of zinbryta is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . if you do not respond well enough to the medicine , your doctor may decide to increase the dose to a maximum of 40 mg twice a day , depending on the results of this blood test . how to inject your medicine you will be given the injection under the skin ( subcutaneously ) in the thigh ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) changes in your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( might affect up to 1 in 100 people ): severe inflammation of the liver may lead to death .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . if you need to use a new syringe / pen , or a refrigerator , please record the date on the label of the pen when you first start using it and the number of days it is stored at room temperature ( not above 30 ). once you have
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 micrograms ( 3 . 0 millilitres ). - the other ingredients are : 1 ml solution for injection ( for injection ) for injection , and for subcutaneous use ( for example , when you are injecting a needle into a syringe ) for the treatment of opioid addiction ( see section 1 ). 2ml solution for infusion : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( e433 ). see section 2 for further information about some of the ingredients
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver to the eyes and brain . this defect leads to liver damage and neurological disorders . wilzin attaches to copper in the intestine and blocks its further accumulation in the body . the action of wilzin slows down the accumulation of copper by the liver and improves the absorption of copper from the body by the brain . the result of this treatment is an improvement in health and life style .
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . your doctor will monitor you closely during the treatment and may adjust the dose of blood and urine if sufficient treatment is required . monitoring 25 insufficient treatment ( copper excess ) may be necessary in case of excessive treatment
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are listed below . how much to take the recommended dose is 25 mg or 50 mg once a day . your doctor will tell you how many capsules of wilzin to take and how long you should continue to take them . the usual dose is 50 mg twice a day for 2 weeks . wilzin 25 mg is available in packs containing 1 to 6 capsules . how long to take wilzin 50 mg or 2 capsules each day . if you have the impression that the effect of wil
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ) very rare ( affects less than 1 users in 1 , 000 ) very small number of patients are known to have gastric irritation at the start of treatment . changes in blood tests , including an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . reporting of side effects
keep out of the reach and sight of children . do not store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each 25 mg hard capsule contains zinc equivalent to 83 . 92 micrograms ( as zinc acetate dihydrate ). each 50 mg soft capsule contains zinc equivalent to zoc ( equivalent to 167 . 84 microgram ) of zinc as zinc ( as magnesium stearate ). the capsule shell is composed of gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e133 ). what wilzin looks like and contents of the pack wilzin 25 mg soft capsules are white to off - white , capsule shaped with wilzin 50 imprinted on one side . the
biktarvy contains the active substance bictegravir . this is an antiretroviral medicine known as an integrase strand transfer inhibitor . the other active ingredient is emtricitabine , an antiviral medicine ( also known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antipirritiral medicine which is a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) in adults . infection with hiv
do not take biktarvy if : you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : - rifampicin , which is used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking bikarvy : if you have or have ever had liver problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is : antacids to prevent stomach ulcers , heartburn and acid reflux , aluminium and magnesium hydroxide mineral supplements , vitamins , magnesium and iron ( see section 2 " important information about some of these medicines "). biktarvy is not recommended for patients on dialysis . talk to your doctor if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . children and adolescents do not give this medicine to children under the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur soon after hiv treatment is started . these symptoms may be due to an improvement in the body ' s immune response , enabling the body to fight infections that have no obvious symptoms . autoimmune disorders , when the immune system attacks healthy body tissue , can occur many months after you start treatment . if you have any symptoms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light .
what biktarvy contains - the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir sodium equivalent to 50 mg film - coated tablet ( tablet core microcrystalline cellulose , croscarmellose sodium and magnesium stearate ). - the other ingredients are film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , talc , iron oxide red ( e172 ), iron oxide black ( e 172 ) and sunset yellow fcf ( e110 ) ( see section 2 ).
novondorm is an oral antidiabetic medicine containing repaglinide , which helps your pancreas make better use of insulin when your blood sugar is high ( glucose ). type 2 diabetes is a disease in which a person does not make enough insulin to control the sugar in their blood or where their body does not respond normally to the insulin it produces . novonorm helps control the level of sugar in your blood after you have started treatment . diet and exercise and weight reduction have been shown to help control the blood sugar ( also called " fat - free ") after a long period of time . your doctor may prescribe
do not take novonorm if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low . if you suffer from diabetic ketoacidosis ( see section 4 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a severe liver disease . you are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). you weigh less than 47 kg . you have liver problems . novon
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . try to take the tablet at about the same time each day . it is best to take it at least 30 minutes before or at least 4 hours after food . do not take more than 30 mg daily for 16 consecutive days . your doctor may want to increase your dose if your blood sugar is too high ( a hypo ).
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm ( may affect up to 1 in 10 people ) is a hypo in section 2 of this leaflet ( see section 2 under " warnings and precautions " for more information ). if this happens to you , tell your doctor straight away . if you do not feel better after this time period , contact your doctor or go to the nearest hospital straight away , as you may need medical attention . signs and symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ). 1 mg tablet contains iron oxide red ( e 172 ) and 2 mg tablets contain iron oxide black , e172 ( see end of section 2 for further information on the contents of this medicine ). what it looks like and contents of the pack no
pumarix is a vaccine used in adults ( from 18 years of age ) to prevent pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . many people get flu at the same time as ordinary flu . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients that may be present in trace amounts as follows : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , tell your doctor or nurse immediately . the vaccine may not fully protect all persons who are vaccinated . medical treatment may be needed in case of an
pumarix is recommended for use in adults 18 years of age and older . pumarix contains a similar h5n1 as03 to those found in the blood . children and adolescents there is no information available on the use in children or adolescents under the age of 18 years . there is limited information on the safety of this vaccine in the following age groups : children from 3 - 9 years old and adolescents from 10 - 17 years old . if you have any questions about how this vaccine works or why this medicine has been prescribed for you , ask your doctor , pharmacist or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure and shock . doctors are aware of this possibility and are emergency treatment available . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness , swelling or warmth at the site of the injection fever sweating shivering diarrhoea ( feeling sick ) uncommon ( likely to affect between 1 in 100 people
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vaccine in the sachet in order to protect from light . after preparation , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at ≤ 30 .
what pumarix contains - the active substance is split influenza virus ( 5 / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . - the other ingredient is haemagglutinin , which is produced by recombinant dna technology ( rdna technology ). in the pandemic , the vaccine contains an ' adjuvant ' as03 , which reduces the amount of the body ' s own immune system ( its own defence system ). this adjuvvant contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants
somakit t is a radiopharmaceutical product containing an active substance called edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride , which is to be dissolved in water for injection before it is given to you . your doctor will decide how much somakit to use and how often you need to use it . it is important that you use this procedure exactly as your doctor has told you . if you have not been trained , your doctor may decide that it would be more convenient for you to inject more of the active substance in a vein or in body areas . somak
do not take somakittoc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you experience any signs of allergic reaction ( see section 4 ). if you have kidney or liver problems . if you suffer from renal or hepatic disease . children and adolescents do not give this medicine to children below 18 years of age because of the risk of dehydration . the examination will be repeated every 28 days . there are others medical conditions that affect the way the body works ( e .
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . 29 in the case of the nuclear medicine doctor supervising the procedure , the nuclear medicines doctor will decide the appropriate dose for you . the usual dose of somakiton to be administered is between 100 mg and 200 mg megabecquerel per kilogram of body weight each day . administration of som
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects : allergic reactions ( hypersensitivity ) have been reported with somakit t . symptoms include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site due to ionising radiation , cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . the following information is intended for the specialist only : somakit t will be stored at a temperature not above 25 ºc . do not freeze . store in the original package in order to protect from light . from a microbiological point of view , the product should be used immediately . in the event of deterioration of radioactive products , the appropriate storage times and conditions prior to use are the responsibility
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotreaotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide and water for injections . - the solvent contains sodium and radiolabelling . the solution contains hydrochloric acid which is used to adjust the amount of radioactivity in the vial . information for radiopharmaceutical preparation is provided in a glass vial with black flip - off cap , containing a white powder
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer in postmenopausal women . it belongs to a group of medicines called non - steroidal aromatase inhibitors , which are used to keep the disease under control . it is used in combination with a medicine called exemestane ( a steroid aromatase inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours that affect the stomach , bowels , lung or panc
always take afinitor exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you what dose of cancer treatment you should take and when to take it . if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before taking everolimus or sirolimus . it is important that you tell your doctor if you have ever had or are likely to have any problems with your liver . in case of any disease affecting your liver , your doctor may prescribe a different dose of afin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg tablet once a day . if you take more afinitor than you should if you have been told you have liver problems , your doctor may prescribe a lower dose of Afinitor ( between 5 mg and 5 mg ) or a higher dose of 7 . 5 mg . the dose may need to be adjusted if you experience certain side effects . your doctor will monitor you closely during treatment . take the tablet pack with you so that you can easily describe what you have taken
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with the combination of the two active substances , with the following frequencies : very common ( may affect more than 1 in 10 people ) - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . open the blister and take the tablets at the same time each day . never take this medicine if you notice any change in the appearance of the tablets or if there are any particles in the tablet or the solution is discoloured ( see section 2 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no
what afinitor contains - the active substance is everolimus . each tablet contains either two or three tablets . - the other ingredient is tablet core : amylhydroxytoluene ( e321 ), magnesium stearate ( e470b ), lactose monohydrate , hypromellose ( e464 ), crospovidone ( e1201 ) and lactose anhydrous ( see section 2 ). what afinitors looks like and contents of the pack afinnitor 2 . 5 mg tablets are white to slightly yellowish , oval - shaped , biconvex tablets debossed with
what laventair ellipta is and what it is used for the active substance in this inhalation is umeclidinium bromide and vilanterol . this belongs to a group of medicines called bronchodilators ( bronchiolabilators ). what you need to know before you use this medicine , tell your doctor or pharmacist if you have or have ever had chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in copd the muscles around the airways tighten . this medicine works by tightening these muscles in the lungs
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have asthma . this medicine should not be used in patients with asthma . you have heart problems , high blood pressure or an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). you have epilepsy , thyroid gland problems , diabetes or severe liver problems .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . this medicine should be used every day for 24 hours . try to use laventair ellipta at the same time each day . do not use more than your doctor tells you to use . it is important that you use it every day and not only when you feel better , but also when your symptoms are getting worse . if you have a sudden attack of breathlessness or wheezing , try to control this attack with a quick - acting reliever
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) redness rare side effects : may affect 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties if you experience any immediate breathing
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose of 55 international units ( iu ) per kilogram of body weight . each delivered dose ( the dose leaving the mouthpiece ) contains either : 55 micrograms of the active substance , euphonylurea ( e1201 ), or 65 micrograms of the other ingredient , emu ( e216b ). - the other ingredients ( excipients ) are : tablet core : lactose , magnesium stearate what lavent
the active substance of tremfya is guselkumab , which is a monoclonal antibody . this medicine contains the active substance " il - 23 ". this belongs to a group of proteins called cytokines , and is used to treat psoriasis in adults and children . it is used in adults with moderate to severe " plaque psORiasis " which is an inflammatory condition that affects the skin and nails . it can improve the condition , the appearance of nails , and reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya : if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have an active infection . you have active tuberculosis warnings , precautions , and follow - up appointments with your doctor or nurse while you are being treated or shortly after you are treated or after you have been treated or have had an infection . your doctor may want to monitor you more closely for signs of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) injected under the skin ( subcutaneous injection ) every 4 to 8 weeks . your doctor will tell you when you should return for the next injection . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . some side effects may be serious ( may affect up to 1 in 10 people ): upper respiratory infections common side effects ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine should not be used if the solution is cloudy or contains large particles . if the liquid is discoloured , it should be thrown away from the refrigerator and returned to the refrigerator . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and
what tremfya contains - the active substance is guselkumab . one ml of each pre - filled syringe contains 100 mg of gusel kumab in 1 ml of solution . - the other ingredients are : histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . see end of section 2 for further information about some of the ingredients . what tremfa looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution , supplied in a carton pack containing one single - dose
the active substance of trepulmix , treprostinil , belongs to a group of medicines called prostacyclins , a hormone produced in the body that lowers blood pressure by relaxing blood vessels , thus preventing them from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adult patients whose condition is persistent or recurrentcteph . it is used either alone or in combination with surgical treatment to improve exercise capacity . symptoms of the disease can vary from patient to patient , but most often are mild to moderate . the most common symptoms
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a disease called " pulmonary veno - occlusive disease ". this is a disease which causes the blood vessels in the lungs to become swollen , leading to a higher pressure in the blood arteries between the heart and the lungs . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : have a heart problem . have had a heart attack ( myocardial infarction )
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( injection under the skin ) through a small tube ( cannula ) in the abdomen or thigh . your doctor will decide on the correct dose for you . the recommended dose is one dose ( 1 mg ) per kg body weight . you will be given one dose in combination with a portable pump containing your treprostinil . instructions on how to use the pump are given at the end of this leaflet . follow the instructions
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain due to the infusion site reaction . this may be the case in some cases . if this happens to you , stop taking trepulmix and contact your doctor immediately . if you experience any of the following , tell your doctor straight away : dizziness , light - headedness or fainting low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgia ), swelling of feet , ankles , legs , fluid retention
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . this medicine does not require any special storage conditions . a trepulmix vial may be stored at room temperature ( up to 30 ) for continuous subcutaneous infusion in a single vial or a single reserve ( syringe ) of undiluted trifampicin for up to 72 hours at 2ºc - 8ºc , unless dilution has taken place in controlled and validated aseptic conditions .
what trepulmix contains - the active substance is treprostinil ( as sodium ). one vial ( 0 . 5 ml of solution for injection ) contains 1 , 000 micrograms ( 3 . 5 milligrams ) treprosticinil and sodium salt . each 10 ml ampoule ( 10 ml ) contains 10 milligram ( 4 . 5 million iu ) of treprostail . - the other ingredients are sodium salt , water for injections , and water for injection ( see section 2 ). two vials ( 1 ml and 2 . 5ml ) contain 2 , 600 microgram
the active substance of thorinane is enoxaparin sodium . this means that it is a low molecular weight heparin ( lmwh ). the active substance in this medicine is a substance called thrombocytopenia . it is used in adults , adolescents and children aged 1 year and above to treat existing blood clots and in children aged 2 years and older to prevent them from re - occurring . your doctor has prescribed this medicine for you because : you have an acute illness called unstable angina . you have problems with your heart such as a heart attack . you are at high risk of blood cl
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ), you should tell your doctor immediately if you have had a reaction such as a severe drop in the number of your clotting cells ( platelets ). this
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding . if the bleeding is severe or if you experience any bleeding event that does not stop immediately , including exceptional weakness , tiredness , paleness , dizziness , headache and unexplained swelling , stop taking your medicine and contact your doctor immediately . if you are not sure , talk to your doctor , pharmacist or nurse before taking this medicine . you may experience a severe allergic reaction which may include difficulty breathing , swelling of the lips , mouth , throat or eyes , blockage of a blood vessel or a blood clot , cramping pain , red
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store below 25 . after dilution the solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2ºc - 8ºc . this medicine is for single use only . the thorinane pre - filled syringes should be disposed of in accordance with local requirements .
what thorinane contains - the active substance is enoxaparin sodium . each pre - filled syringe contains 100 micrograms ( 0 . 2 millilitres ) of solution for injection in a vial ( equivalent to 2 , 000 microlitres ). - the other ingredient ( s ) ( excipients ) ( for reconstituted and diluting solution for infusion ) ( see section 2 ) is : white to off - white , colourless type i neutral glass syringe barrel with fixed needle and needle shield with chlorobutyl rubber stopper and a blue polypropylene plunger rod . what
senstend contains two active substances : lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , helping to control the rate of ejaculation .
do not use senstend : - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . if you have a history of allergy or sensitivity to local anaesthetics ( e . g . amide - type local anahetics ), a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ), anaemia ( methaemoglobinaemia ). medicine sensitivities and sensitivity can be serious and can lead to severe liver problems .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 1 spray ) on the head of your penis once a day for 3 days , followed by 24 hours ( corresponding to 4 sprays ). use the spray container at the same time each day . follow the pump mechanism to avoid contact with eyes , nose , mouth and ears . after using the pump , apply 1 spray to the inside of the foreskin of your head . do not touch your penis with the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with senstend : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( might affect up to 1 in 100 people ) headache local irritation of the throat , irritation on the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the penis pain or discomfort when the penis itching when the area around the penis is exposed to a high temperature other side effects include : common (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the metal container after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . after first opening , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 12 hours at 2 to 8 , unless dilution has taken place in controlled and validated aseptic conditions
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 micrograms ( 0 . 5 milligrams ). - each spray container contains 50 microlitres ( 1 . 5 ml ). - the other ingredients ( excipients ) are lidocaine 50 mg and 7 . 5 mg ( respectively ). - both of these active substances must be dissolved in water for injections before use . - each dose contains either 2 . 5 to 5 mg of prlocaine per ml , either at the same time each day or in a different way each day .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma can be treated with complete resesection in adults ( treatment without surgery or adjuvant therapy ). advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma has been previously treated with an autologous stem - cell transplant or with a transplant . advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) a medicine called nivolumab , which is a monoclonal
do not take opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given opDivo if : - you notice problems with your heart such as a change in the rhythm or an abnormal heart rhythm . - your lungs have breathing difficulties or cough . - you have inflammation of the lungs ( pneumonitis or interstitial lung disease ). - you get diarrhoea , watery , loose or soft stools , or any symptoms of inflammation of any intestines (
always take opdivo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose for adults and children weighing at least 240 kg is one 240 mg tablet once a day ( corresponding to 2 x 480 mg per kilogram of your body weight ) for 4 weeks . your doctor will prescribe the strength that is right for you . if you cannot take ipilimumab with food , the treatment will be stopped . for the treatment of skin cancer , your doctor may prescribe the same dose as 1 mg of nivolumab per kil
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store below 25 for 48 hours . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( corresponding to 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg or 240 mg of 20 mg of 25 mg of 30 mg of 50 mg of 40 mg . - the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 under " important information about sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water
clopidogrel tad contains clopridogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombolybosis ). clopidogsreltad is taken by adults to reduce the number of bloodclots ( thrombi ) that can form in hardened blood vessels ( arteries ), a process
do not take clopidogrel tad : if you are more than 30 years of age . if you think you may be allergic , or if you have been told by your doctor that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain ; if you suffer from severe liver disease . if any of the above applies to you , or you are not sure , talk to your doctor , pharmacist or nurse before taking this medicine . warnings and precautions the following apply to you and to any member of your family or carer : - if you currently have or have ever
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a different dose . the usual starting dose , which is 300 mg taken once daily , is two 75 mg tablets taken once a day
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel tad contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide [ e172 ]) in the film coating . tablet coating : talc andmacrogol 3000
tacforius contains the active substance tacrolimus , which is an immunosuppressant . after your organ transplant ( liver and kidney ), your body ' s immune system will try to reject the new organ . tacforius is used to prevent rejection of transplanted organs by the liver , kidney and heart after any previous treatment you were taking at the time of your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , any macrolide ( antibiotic ), erythromycin , clarithromycin or josamycin . warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment , if any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice before you are given this medicine . if you have been previously treated for other conditions , tell your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor who is experienced in the use of this medicine . transplant patients should take the same tacrolimus medicine as adults . however , if you have had a transplant , your doctor may prescribe your own medicine . your doctor will tell you to take your first dose of tacforius at the same time each day . do not take a double dose to make up for a forgotten dose . you should continue taking this medicine until your doctor tells you otherwise . if you
like all medicines , this medicine can cause side effects , although not everybody gets them . infections tell your doctor or nurse straight away if you notice any of the following serious or potentially life - threatening infections while you are being treated with tacforius : severe effects including allergic and anaphylactic reactions ( benign and malignant tumours ) have been reported in patients who have been treated before and who have returned to normal or who have not responded to treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis ( a severely lowered number of white blood cells ), ha
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . after first opening the aluminium wrapping , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains - the active substance is tacrolimus . each capsule contains 0 . 5 mg . each prolonged - release hard capsule contains a total of 1 mg of tacrulimus ( as monohydrate ). each capsule is available in three different strengths . - the following strengths may be used for each prolonged release capsule . - each long - release capsule contains 1 mg or 5 mg of the active substances , respectively ( see section 2 ). - each soft release capsule releases 3 mg or 3 mg of each active substance , respectively " ( see below for further information on the contents of the capsules ) - each hard release
clopidogrel zentiva is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the time that this clumping takes to stop the formation of blood clots ( thrombi ) it makes hardened blood vessels ( arteries ), a process known as atherothrombosis , less likely to happen . in a few cases , patients may be at increased risk of having a stroke , heart attack , or death . you have been prescribed
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopiperrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you ( or you are in any doubt at all ), tell your doctor or pharmacist . warnings and precautions it is important that you and your doctor know what you are taking and what precautions you need to take to avoid the effects of clop
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose ( 300 mg one day , followed by 300 mg two days later ), and a further 300 mg tablet ( 4
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . clopidogrel zentiva is for single use only . aluminium blisters : do not store above 30 . store in the original package in order to protect from moisture . bottle : keep the bottle tightly closed . keep the cap on the bottle to prevent moisture from entering . blister : after first opening of the bottle , the bottle may be kept at room temperature ( up to 30 ). do not
what clopidogrel zentiva contains the active substance is clopidoogrel . each tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients ( excipients ) are listed in section 2 under ' important take - out substances ' for the tablet core : lactose , water for injections ( see section 4 ), microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ), triacetin , red iron oxide ( e172 ), titanium
yttriga is a radioactive medicine that must not be used after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . it is stored in the original package in order to protect from light . the product is not to be mixed with another medicine . tiny radiation doses are used for the treatment of radiolabelled medicinal product .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your nuclear medicine doctor , pharmacist or nurse before you are given this medicine if : - you are pregnant , think you may be pregnant or are planning to have a baby . - you have been breast - feeding for a long time . do not give this medicine to children under the age of 16 years . - this medicine has not been studied in this age group . - the safety and efficacy of other medicines please tell your nuclear
your doctor will supervise the treatment . method of administration yttriga is for radiolabelling of medicinal products for specific diseases . your doctor will decide on the appropriate dose for you . the treatment will be initiated under the supervision of a physician experienced in the care of patients with a history of overdose . appropriate treatment is recommended .
like all medicines , yttriga can cause side effects , although not everybody gets them . you can report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . local regulations on radioactive substances are in place to protect the environment . any unused product or waste material should be disposed of in accordance with local requirements .
what yttriga contains the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). the vial is closed with a v - capped bottom . it is supplied in a colourless type i glass vial of 10 ml with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . the active substance in ciambra , cisplatin , is another anti - cancer medicine . it is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , when no other treatment has been available or when patients have not received prior chemotherapy . in this case , the other active ingredient in the medicine ( s ) will be taken from you and given to you by your doctor as an injection before the initial treatment . if you have lung cancer that has spread to your other organs , ciam
do not use ciambra : - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before breast - feeding . before starting treatment , you should tell your doctor if you have recently received or are about to receive a vaccine against yellow fever . your doctor may decide to delay or discontinue treatment with ciamBra . if you currently have or have previously had problems with your kidneys , your doctor will decide whether you should be treated with Ciambra . before each infusion , your
the recommended dose of ciambra is 500 mg based on your body ' s surface area . your height and weight are measured to work out the surface area of your body . your doctor will work out your dose based on this body surface area and will adjust your dose and duration of treatment depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the cimbra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . the infusion will be given by infusion into one of your veins and will last approximately 10 minutes .
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38ºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or have a fast heart rate ( uncommon ). if you are having pain , redness , swelling or sores in your mouth ( common ). allergic reaction : if you develop skin rash
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . the infusion solution of pemetrexed should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 and 15 to 25 . the reconstituted solution must be used within 24 hours or discarded . if you use more ciambra than you should
what ciambra contains - the active substance is pemetrexed . each vial contains 100 mg / ml of solution for infusion , corresponding to a concentration of 100 micrograms / ml ( 0 . 5 milligrams ) of pemrexed ( as pemetretrexed disodium hemipentahydrate ). each piambra 500 iu / ml vial provides an additional 500 mpa . s of powder for concentrate for solution for injection . - the other ingredients are : mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) that help fight certain infections in your blood . immunogam can be used in adults and children of all ages . it works by reducing the activity of increased levels of human hepatitis b immunoglubulins , and by blocking the action of another protein in the body , immunoglofulin g ( ig ), which is produced naturally in the blood plasma of infected people . what immunogaman is used for Immunogam is used to treat hepatitis b virus in haemodialysed patients who have not previously had vaccination .
immunogam must not be used : - if you have ever had an allergic reaction to human immunoglobulins or other blood products , or to any of the other ingredients of immunogam ( listed in section 6 ). if you know that you have an iga deficiency , you must tell your doctor immediately , as you may be at increased risk of having an allergy reaction to iga containing products . children and adolescents ( aged 18 years and older ) who have not been previously treated with immunoglobinins have experienced adverse reactions such as chills , headache , fever and vomiting . allergic reactions have also been reported
always use immunogam exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . vaccination against hepatitis b virus the first vaccine dose will be given in combination with human hepatitis b immunoglobulin ( hbv ). dose and administration prevention the recommended dose of hepatitis b is 500 micrograms given every 24 hours for up to 72 weeks . your doctor may decide to increase your dose to hepatitis b in haemodialysed patients ( 500 iu / kg ) given every 2 weeks by means of seroconversion . the recommended duration of vaccination depends on the type of
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ): very common : may affect up to 1 in 10 people 1 , 000 cases very rare ( affects less than 1 users in 10 , 000 ) if any of the side effects gets serious , or if you notice any undesirable effects not listed in this leaflet , please tell your doctor or pharmacist .
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light and moisture . immunogogam should not be used if the solution is cloudy or contains deposits . medicines should not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin ( hbv ). - one vial contains 1 mg or 5 mg of human plasma protein , corresponding to a concentration of 96 kbq / ml . - the other ingredients are polysorbate 80 and water for injections ( see section 2 ) and solvent for solution for injection in a glass vial , which is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial .
remicade contains the active substance infliximab . infliximab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfα ). remicade belongs to a group of medicines called ' ntp blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ) and psoriasis in adults , adolescents and children aged 6 years and older . these include crohn '
do not take remicade : - if you are allergic to infliximab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic ( hypersensitive ) to the active substance , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are taken . if you have ever had tuberculosis ( tb ) or another serious infection , e . g . pneumonia , sepsis or heart failure , tell your doctor straight away . if any of these apply to you , your doctor may need to change your dose or stop remic
what remicade is used for the treatment of : rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases the usual starting dose is 5 mg for each kg of weight . your doctor will decide the dose that is right for you . how and for how long you will be treated your doctor may decide how many treatments you will need . the recommended dose is one infusion ( drip ) over 2 hours into one
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and may require treatment . tell your doctor or nurse straight away if you notice any of the following side effects during or after your treatment with remicade : - signs of an allergic reaction such as swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are rare , but you should be aware of the possibility of having an allergic
remicade will be stored by the health professionals at the hospital or clinic . the storage details are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after reconstitution , remicade can be used for infusion . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be
what remicade contains - the active substance is infliximab . each vial contains 100 mg of inflixamab . after reconstitution , each ml contains 10 mg / ml of solution for injection ( see section 2 ). - the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate , water for injections and other non - reconstituted ingredients . what remicades looks like and contents of the pack remicada is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine that is used to treat the condition ). although there is no evidence of the disease being caused by parkinson ', it is thought that the disease is due to a loss of cells that produce dopamine in the brain . dopamine is a chemical that is essential for the brain to work properly . movement control is thought to work by helping your body make better use of its own dopamine .
do not take rasagiline mylan : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you have severe liver problems . warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : - rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used in the treatment of depression and parkinson ' s disease . - medicinal or natural products containing st . john ' s wort . - pethidine , a strong pain killer . children and adolescents do not give this medicine to children or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . you can take rasagiline mylan with or without food . try to take your daily dose at about the same time each day . it is important that you do this every day until your doctor tells you otherwise . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet before swallowing . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of rasagiline mylan are similar to those of placebo . the frequency of possible side effects listed below is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare ( may affect up to 1 in 1 , 000 people ) fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite , constipation , dry mouth
what rasagiline mylan contains - the active substance is raspiline . each tablet contains a single dose ( 0 . 5 mg ) of rasagailine tartrate . - the other ingredients ( excipients ) are : tablet core : microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( maize ), talc , stearic acid , and water for injections . what rasago mylan looks like and contents of the pack rasagleiline tablets are 11 . 5 mm x 6 mm , biconvex tablets deboss
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe infection such as tuberculosis ( see section " warnings and precautions "). symptoms of infections may include fever , wounds , feeling tired , dental problems . if you suffer from moderate or severe heart failure or have a serious heart condition . if any of these apply to you , tell your doctor . allergic reaction . allergic reactions may include symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . these reactions are usually mild to moderate and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years of age weighing 10 kg or more the usual dose is 30 mg once a day . hulio may be prescribed as 20 mg twice a day ( see section 2 ) if your child is from 2 - 17 years old weighing less than 30 kg , your doctor will prescribe you a lower dose ( 20 mg two times a day ) of one 40 mg tablet . enthesitis - related arthritis in adolescents from 6
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may require urgent medical treatment . tell your doctor straight away if you notice any of the following serious side effects ( which may occur up to 4 months after the last hulio injection ): allergic reaction including heart failure , severe rash , hives swollen face , hands or feet , trouble breathing or swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections ( see end of section 2 under ' important information about some of the ingredients '). what hulaio looks like and contents of the pack haulio 40 mg solution for injection in a vial is a sterile solution containing 40 mg / ml ( 0 . 8 % w / w ). the solution is clear to slightly opalescent and has a rubber stopper . hul
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which are used to reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using yellox if you have asthma , skin allergy or intense inflammation in your nose . you should not use other nsaids ( e . g . acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine should not be used in combination with topical steroids such as cortisone , as it may increase the risk of unwanted side effects .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in the affected eye ( s ) once a day . if you use more yellox than you should if you accidentally use too many drops , talk to a doctor or go to a hospital straight away . how long to use use the drops every day for the next day after your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 milligrams ( mg ) of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution
duvovoveo contains sufentanil , which belongs to a group of strong painkillers called opioids . it is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo : if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before taking dzuvoo if you : have any condition that affects your breathing ( e . g . asthma , wheezing or shortness of breath ) tell your doctor or pharmacist if any of these apply to you . your doctor may need to adjust your dose or stop treatment . have recently had a head injury or brain tumour . have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet before swallowing . you can take dzuveo with or without strong painkillers such as sufentanil . the recommended starting dose is 30 mg once a day . the sublingual tablet should be taken orally with a sufficient amount of food . use the disposable single -dose applicator provided in the pack . remove the applicator from
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : - severe breathing problems , especially slow and shallow breathing . stop taking dzuveo and see a doctor immediately . very common side effects ( may affect more than 1 in 10 people ): - nausea , feeling sick , vomiting , being sick and feeling hot . common side side effects that may affect up to 1 in every 10 people : - inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy , increased
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . this medicine does not require any special temperature storage conditions . if you notice any visible sign of deterioration , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each single - dose tablet contains 30 mg . - the other ingredients ( excipients ) in the tablet core are : citrate , mannitol ( e421 ), dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearate . the tablets are white to off - white with round edges and are supplied in cartons containing 3 tablets . each carton contains asingle - dose applicator ( labelled [ sublingual tablet ]
elleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . it also helps to prevent sensitive prostate cancer from returning to the body after surgical treatment . it reduces the levels of testosterone in the blood in men with resistant prostate cancer . erleada also blocks the action of androgens , which are involved in the growth and spread of the cancer . by blocking androgens the medicine works by inhibiting the growth of prostate cancer cells .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to become pregnant ( see section " pregnancy , breast - feeding and contraception section "). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine may cause seizures . tell your doctor if you take , have recently taken or might take any medicines that may increase the risk of blood clots ( e . g . warfarin , acenocoumarol ) if you have any heart
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg twice a day . your doctor may increase your dose to 60 mg once a day depending on how you respond to erleada . taking this medicine by mouth is the best way to reduce the risk of side effects . you should swallow the tablets whole with a glass of water . do not crush , chew , or break the tablets . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . taking other medicines please tell your
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis is a group of serious side effects . the most common side effects are fits ( seizure ) which may affect up to 1 in 100 people
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of appalutamide ( as mesilate ). - the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silica ( e460 ), talc , and titanium dioxide ( e171 ). film - coating : iron oxide black ( e172 ), iron oxide yellow , macrogol , polyvinyl alcohol ( partially hydrolysed ), tal
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used to carry out scan ( a pet scan ) in adults who have previously had treatment for prostate cancer . it can be carried out with other tests that measure prostate specific antigen ( psa ), the type of protein present in the cancer . an axumin pet scan can help to determine whether the cancer has spread and whether the scan has been carried out . your doctor will decide if axumin is suitable for you . if you have any further questions on the use of this procedure , ask your doctor , pharmacist
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using axumin if you have kidney problems . you must follow a low sodium diet . axumin is given once a day for the duration of the axumin scan ( see section 4 for more information ). during the scan , you will be given your usual medicines to take during the latest 60 minutes before and at least 60 minutes after your axumin injection . do not urinate during or after the scan . children
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used in each case . the usual dose is 370 megabecquerel per kilogram of body weight . how axumin is given for the procedure axumin must be injected into a vein by a flush of sodium chloride solution
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( affects more than 1 user in 100 ) the effects of the medicine were mild . uncommon ( affects 1 to 100 users in 1 , 000 ) the side effects of axumin were mild to moderate and occurred in less than 1 in 100 users . however , pain , rash , altered taste in the mouth and altered sense of smell were reported . this radiopharmaceutical emits low amounts of ionising radiation which may increase the risk of cancer and hereditary abnormalities . reporting of side effects
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . do not use axumin after the expiry date which is stated on the label and carton after exp .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( corresponding to 1600 to 16000 iu ). axumin 3200 mg / ml : each millilitre ( 0 . 3 %) of the reconstituted solution contains 3200 micrograms ( 3200 to 32 000 iu ) - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin is sodium "). what axumin looks like and contents of the pack white to off
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . if the pressure in your eye is too high , it can damage your sight .
do not take azopt if you have severe kidney problems if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor , pharmacist or nurse before taking azopt . the same allergy may apply to some patients who have too much acidity in their blood ( hyperchloraemic acidosis ). if any of these apply to you , tell your doctor or pharmacist before
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt should only be used in the eyes . the recommended dose is 1 drop in the affected eye each day . do not use azopt in both eyes at the same time each day ( see section 1 , 2 , 3 ). before using the azopt bottle , wash your hands . remove the cap . the cap can be removed with a snap collar . hold the bottle , pointing down , between your thumb and middle finger . tilt your head back . pull down your eyelid with a clean finger until
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects on the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects affecting the eye include : - sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching and redness , swelling or deposits in eye , glare ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . this medicine does not require any special temperature storage conditions to protect from infections . a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each vial contains 10 mg of a suspension . - the other ingredients are : benzalkonium chloride , carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide to maintain acidity levels ( ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack containing three
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines ( medicines taken by mouth ) used to treat diabetes . it works by reducing the amount of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ) to treat a type of diabetes called type 1 diabetes . this is when your body does not make enough insulin or if the insulin that your body makes does not work as well as it should . in some people , this can lead to diabetes . you may also be overweight or obese . type 2 diabetes : your body hardly makes enough insulin
do not take forxiga : - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking for xiga if you : - experience feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath or a sweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . contact your doctor or pharmacist immediately if you have one of the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is between 10 mg and 5 mg once a day . if you have a liver problem , your doctor may prescribe a lower dose . your doctor will tell you how many tablets to take and how often to take them . how much to take your doctor can tell you if you need to take the tablets with or without food . it is important that you continue to follow the advice about diet and exercise given to you by your doctor , pharmacist or nurse
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking forxiga and see a doctor straight away if you notice any of the following serious side effects : angioedema ( rare , may affect up to 1 in 10 , 000 people ): angioEDema may cause swelling of the face , tongue or throat which may cause difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( rare ), if you have type 1 diabetes ( very common ), or if you are more than 10 years of age . type 2 diabetes : rare , but at least 1 in 1 ,
what forxiga contains ∑ the active substance is dapagliflozin . ∑ eachforxiga 5 mg film - coated tablet ( tablet ) contains : ∑ a single tablet ( containing a pbq ) ∑ two tablets ( with a nominal amount ( 0 . 5 milligrams ). ∑ three tablet strengths ( e470b and e553b ): ∑ tablet core : microcrystalline cellulose , lactose ( see section 2 ' for important information about lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating : polyvin
mifamurtide works by stopping the growth and spread of certain bacteria by the immune system . mepact is used to treat adult patients with osteosarcoma ( bone cancer ) that has spread between 2 and 30 years after surgery to remove the tumour . it is used when chemotherapy has stopped the growth of cancer cells and cancer has come back .
do not take mepact if : you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines containing ciclosporin and other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ) ( nsaids ). you have problems with your heart or blood vessels such as blood clots ( thrombosis ), bleeding ( haemorrhage ) or inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor , pharmacist or nurse before starting treatment : if you have long - lasting
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you how many tablets to take and how long you should continue to take it . the recommended dose is one 2 mg tablet of mifamurtide every 12 hours for 24 hours . your doctor may change your mepact treatments according to your chemotherapy schedule . if you have any further questions on the use of this medicine , ask your doctor . duration of your chemotherapy 36 the duration of
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported very commonly in patients receiving mypact ( transient use of paracetamol ) and have been associated with fever . your doctor may decide to reduce the dose or stop treatment temporarily or permanently . tell your doctor immediately if you develop any of the following stomach problems ( nausea , vomiting and loss of appetite ) after you have received chemotherapy . contact your doctor if you experience continuing fever and chills after 8 weeks of treatment with mepacts . signs of an infection such as rash or any problems
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial in outer carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 30 ) for up to 6 hours prior to use . this medicine does not require any special temperature storage conditions . any unused product or waste material should be disposed of in accordance with local requirements . in the event
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mifamanurtide ( as besilate ). after reconstitution and suspension , each ml contains 0 . 08 mg / ml ( 0 . 07 % w / w ). the other ingredients are 1 - palmitoyl - 2 - ol - sn - glycero - 3 - phosphocholine ( see end of section 2 ) 2 - dileoyl , sn - gglycero- 3 - phosphate - l - serine monosodium salt ( see section 2 ). what me
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . mirvaso is used on the skin and in the face to reduce redness associated with rosacea ( redness of the face ) and to reduce the amount of blood flow in the facial skin associated with enlargement ( dilution ) of the small blood vessels of the skin . by blocking these blood vessels , it prevents the excess blood flow and redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . the medicine should not be injected under the skin . if you take certain medicines used to treat depression or parkinson ' s disease ( monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracyclic antidepressant such as map
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso should only be applied to the skin on the face . this medicine should not be injected into any other part of your body . do not use it on body surfaces , such as your eyes , mouth , nose or vagina . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . how much to use the recommended dose is one gram ( 5 pea sized amounts ) twice a day . depending on how you respond to the treatment , your
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( may affect up to 1 in 10 people ): worsening of rosacea . stop the treatment immediately and contact your doctor if you have symptoms ( see section 2 " warnings and precautions "). contact allergy : allergic reaction including rash , rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . store in the original package in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . each millilitre of gel contains 3 . 3 mg ( 1 . 5 mg ) bimonidine tartrate . - the other ingredients are : carbomer , methylparahydroxybenzoate ( e218 ), phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 under " miraso contains methylparhydroxy benzoate ") and shellac ( e904 ). what mirvasoa looks like and contents of the pack mir
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body from infection and cancer by blocking the activity of a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of lymph vessels and other parts of the body where it stimulates the vein gf protein ( a substance that allows blood vessels to expand and provide them with oxygen ). by blocking this protein , bev
you must not be given this medicine : if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may ( or might not be able to be allergic ) to chinese hamster ovary ( cho ) cell products . if you ( or may be pregnant ) are breast - feeding . warnings and precautions talk to your doctor before you are given mvasi if : you have an increased risk of developing holes in the gut wall ( inflammation inside the abdomen ), diverticulitis ( stomach ulcers ), colitis or
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the usual starting dose is between 5 mg and 7 . 5 mg . the dose may be increased to 10 mg or 15 mg depending on the size of your tumour . your doctor may decide to keep you under closer observation or change your dose depending on your general condition and on how well you respond to treatment . if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor or pharmacist . you will usually receive m
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : tell your doctor or nurse straight away if you notice any of the side effects listed below . these effects are usually mild to moderate and usually disappear after a few days to a few weeks of chemotherapy . these side effects can be serious and should not be given to anyone else . if any of these affects you , tell your physician or nurse immediately . warnings and precautions talk to your doctor , nurse or pharmacist before you are given this medicine : - allergic reactions . signs of an allergic reaction may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . after dilution , chemical and physical in - use stability of infusion solutions has been demonstrated for 24 hours at 2 to 8 oc . from a microbiological point of view , the infusion solutions should be used immediately . in a sterile environment , dilution should be performed in accordance with local requirements . in this case , the product should be stored in a refrigerator ( 2 - 8 )
what mvasi contains - the active substance is bevacizumab . each ml of concentrate contains 25 mg / ml ( 1 . 4 mg / 16 . 5 ml ) solution for injection . each 4 ml vial contains 100 mg ( 2 . 0 mg / 25 ml ) of solution for infusion . after dilution , the solution is clear to opalescent and colourless to pale yellow . - the other ingredients are : trehalose dihydrate , sodium phosphate , polysorbate 20 ( e433 ) and water for injections ( see end of section 2 ). what it looks like and contents of
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used when other medicines have not worked well enough or are not suitable . tecartus contains the active substance cd19 , which is a type of white blood cells called autologous anti - cd19 - transduced cd3 + cells that are produced by your own immune system ( the body ' s own defense system ) and contain the b - lymphocytes that are involved in the cell growth and division of the blood ( also called lymphocyte - colony stimulating factor [ lymphocytes ]) and is produced by the body in an uncontrolled way
do not use tecartus : if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using the medicine if : you have a problem with the number of white blood cells in your blood ( lymphodepleting chemotherapy , see section 3 ) you have low numbers of a type of whiteblood cells ( autologous use ). your doctor may do tests ( checks ) to check your lungs , heart , kidney , blood pressure ,
tecartus contains your own white blood cells . your cells will be collected and given to you by a doctor or nurse through a catheter placed in your vein ( a procedure call leukapheresis ). it is very important that you get all of yourwhite blood cells in your blood as soon as possible . the first dose of your blood will be given into a vein over 3 to 6 hours . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . how much tecartus is given your doctor will decide how many treatments you need . the number of your white
like all medicines , this medicine can cause side effects , although not everybody gets them . if your side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or nurse . you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure with symptoms such as dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness ). decreased level of consciousness may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion bag contains liquid nitrogen equivalent to 150 ml . this medicine contains genetically modified human blood cells and human - derived material . after dilution , the product should be used within 36 hours .
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3 + cells . each patient - specific single infusion bag contains a dispersion of anti - cd19 car t cells in approximately 68 ml ( corresponding to 2 x 106 anti ) cells . - the other ingredients are sodium chloride and human albumin ( see section 2 for further information about some of the ingredients of this medicine ). - the concentrate for solution for infusion is reconstituted in an infusion bag contained in a metal cassette . once a patient has been trained , the resulting product is presented as a single infusion
januvia contains the active substance sitagliptin which belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which are used to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your condition . januvia can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas
do not take januvia : if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking januuvia if : you have ( in section 4 ) blistering of the skin ( bullous pemphigoid ) if any of these apply to you ( or you are not sure ), tell your doctor or pharmacist as soon as possible before taking this medicine . you have , or have ever had , a disease of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may increase your dose to 25 mg or 50 mg once daily depending on how you respond to this medicine . your doctor will tell you how many tablets of this medicine to take . this medicine may be taken with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important that you continue to take januvia as long
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back , with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ): rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film - coating : poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide [ e172 ]). what janu
xultophy lowers blood glucose in patients with type 2 diabetes mellitus . diabetes is when your body does not make enough insulin , or the insulin that your body produces does not work as well as it should . this leads to an increase in blood sugar . your doctor has prescribed insulin degludec ( a long - acting basal insulin ) to help control your blood sugar levels . liraglutide ( another type of glp - 1 medicine ) is a substitute for insulin during meals . xultophy is also used in combination with oral medicines for diabetes . it is important to follow the advice about oral medicines given
do not take xultophy : - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). - if 39 you are taking a sulfonylurea such as glimepiride or glibenclamide . your doctor will tell you how long you should continue to take this medicine . if you have type 1 diabetes mellitus or ' ketoacidosis ' ( a condition where your blood sugar levels are too high ). warnings and precautions talk to your doctor , pharmacist or nurse before you start taking xult
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day . do not take more than one tablet in the morning , with breakfast , with dinner . if you have been blind or have poor eyesight , your doctor may need to adjust your dose to maintain your blood sugar level . your doctor will tell you how many tablets of xultophy you need to take and how long you should continue to take them . the usual starting dose is 41 mg twice a day ( 1 tablet of insulin deg
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : low blood sugar ( very common : may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . this could be a sign of serious hypoglycaemia ( which may cause brain damage ). if you are not sure what to do , talk to your doctor , pharmacist or nurse before taking xultophy . warnings and precautions if you experience any of these conditions , contact your doctor right away . low blood
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . after first opening : store in a refrigerator ( 2 - 8 ). do not freeze . store in the original package in order to protect from light . after opening : chemical and physical in - use stability has been demonstrated for 8 hours at room temperature ( 20 - 25 ). from a microbiological point of view , xultophy should be used immediately . however , if not used immediately , in -
what xultophy contains - the active substances are insulin degludec and liraglutide . each vial contains 100 units of insulin degluudec 3 . 6 mg / ml ( corresponding to a concentration of 300 units / ml ). - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xulophy contains sodium "). what xultphil looks like and contents of the pack xultoph is a clear , colourless solution for injection in a multipack
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ) and her2 [ erbb2 ] ( erbb3 ]. these proteins are involved in the growth and spread of cancer cells . this medicine blocks the growth of these proteins and slows down the rate at which they die . by blocking their growth , this medicine stops them from multiplying and growing . this will help to stop cancer cells from growing . your doctor has prescribed this medicine for the treatment of cancer of the lung ( non -
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ). if you have low body weight ( less than 50 kg ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have kidney problems . this is because this medicine can cause lung inflammation ( interstitial lung disease ). you have liver problems . your doctor may need to perform some liver tests before and during treatment with this medicine . you have a severe liver disease . you suffer from eye problems such as severe dry eyes , inflammation of the transparent layer
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . your doctor will tell you how many tablets of this medicine to take . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . do not crush , chew or break the tablet before swallowing . this medicine is for oral use . take the tablet at least 1 hour before or 3 hours after food . if you take more this medicine than you should if you accidentally take too many tablets , contact your
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment : diarrhoea ( very common , may affect more than 1 in 10 people ). if you have diarrhoehoea , see section 2 under " warnings and precautions " for more information . if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . severe dehydration ( with or without fluid loss ) has been reported very commonly ( may affect up to 1 in every 10 people ) in patients with low blood potassium and worsening kidney function . if
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afinib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections ( see section 2 under ' important information about some of the ingredients ') and sunset yellow fcf ( e110 ) in the tablet core .
the active substance in orkambi is lumacaftor . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older . it works by blocking a protein called f508del mutation ( cftr ) in the gene responsible for the protein . this protein is found in cells called " transmembrane conductance regulator " ( tmsr ), which are involved in transmitting signals to and from the lungs . the mutation causes an abnormally high level of a protein in the body called " cpr " that is important for your breathing and for your
do not take orkambi : - if you are allergic to lumacaftor , ivapaftor or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given and during treatment , if any of these apply to you . children and adolescents do not give this medicine to children or adolescents under the age of 6 years . do not breast - feed your child while you are being treated with either kambi . the f508del mutation is not known in this age group . if you have liver or kidney disease , your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 6 mg tablet once a day for the first 12 weeks . your doctor will tell you how many tablets to take . the recommended orkambi tablet is 6 mg twice a day in the morning and 11 mg twice daily in the evening . the dose may be adjusted by your doctor if you need to take a higher or lower dose . if you have moderate or severe problems with liver function , your doctor may decide to reduce the dose or stop giving you or
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi in combination with ivacaftor are usually mild to moderate and of a short duration . however , some patients may experience serious side effects . some of these effects may be serious and need immediate medical attention . if you have any of the following , stop taking or kambi and tell your doctor straight away : raised levels of liver enzymes in the blood which may increase the risk of liver injury in patients with pre - existing severe liver disease and the worsening of liver function . the following side effects have
what orkambi contains - the active substance is lumacaftor . - each tablet contains either ivacaftore ( as besilate ) or two other ingredients ( e . g . povidone ( k30 ), which are contained in the tablet core ). - each of the three active substances is contained in a separate sachet ( sachet ) or can be swallowed whole with a glass of water . - the 100 mg / 125 mg film - coated tablet contains only one or two different active substances , each containing one or more of the following active substances : - olaconazole ( e12
what lynparza isLynparza contains the active substance olaparib , which is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in some types of cancer , parp inhibitors cause death by stopping cancer cells from producing an enzyme needed to repair dna . what it is Lynparza used for the treatment of patients with ovarian cancer ( brca - mutated ovarian cancer ) it is used when the cancer has responded to previous
you must not be given lynparza : - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents do not give this medicine to children less than 6 years of age . the use in children below 2 years is not recommended . if you have any further questions on the use of this product , ask your doctor or pharmacist . driving and using machines do not drive or use any tools or machines until you have established your own ability to drive and use
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of lynparza is one 100 mg capsule twice a day . your doctor may increase your dose to 150 mg once a day depending on how you respond to the dose . the doses of Lynparza capsules and tablets should be taken at the same time each day . if you take more than one tablet a day , take it as soon as you remember and then take your next dose at the usual time . do not take a capsule in the evening . how to take
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( might affect up to 1 in 100 people ): allergic reactions such as hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects tell your doctor , pharmacist or nurse if you notice any of the following : very common side effects ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . any lynparza capsules should be disposed of in accordance with local requirements . store in the original package in order to protect from moisture . after first opening : store in a refrigerator ( 2 - 8 ). do not freeze . store at room temperature ( up to 30 ) for a single period of up to 3 months . discard any capsules that have been accidentally frozen . the capsules must be returned to the
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what the hard capsule looks like and contents of the pack white to off - white opaque , hard capsule imprinted with the company logo on one side and the number " 50 mg " on the other side . plain on the cap and the astrazeneca logo on the
this medicine contains the active substance naloxone which is used to reduce the effects of opioids ( such as heroin , methadone , fentanyl , oxycodone , buprenorphine , morphine ). nyxoid is used as a nasal spray during the emergency treatment of opioid overdose in adults , adolescents and children aged 14 years and above . overdose can lead to breathing problems and severe sleepiness . if you experience an opioid overdose , stop taking opioids and seek emergency medical care immediately .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . you may need emergency medical care or emergency services if you think you may have an opioid overdose . it is important that you immediately contact your doctor if you have any questions about the signs and symptoms that may be associated with an overdose . if you forget to use this nasal spray if you miss a dose , take it as soon as you remember and then go back to your regular dosing schedule
always use nyxoid nasal spray exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . 1 . symptoms should be : shoulders , ears , breastbone , sternum or inside the ear . fingernail . 2 . clear the mouth and nose of any blockages . breathe in through the mouth or nose . 3 . breathe out through the nose . 4 . breathing is the chest moving through the chest . you may hear breathing sounds and breath on the cheek . overdose may be life - threatening . response to touch or sounds , slow uneven breathing , breathing
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and seek urgent medical attention : acute withdrawal symptoms have been reported in patients taking opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . this is uncommon ( may affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . one dose of each nasal spray contains 1 . 8 mg ( 10 mg / ml ). - the other ingredients ( excipients ) are hydrochloride dihydrate , trisodium citrate diydrate , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . - the total amount ( mg ) ( 0 . 1 ml ) of solution for injection in a pre - filled nasal spray can be divided into equal doses . a single dose container should be sufficient for one dose . what nixoid looks like and contents of
this medicine contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). fsh is involved in the growth and development of the sacs ( follicles ) in the ovaries . it is used for the production of sperm ( a immature egg cell ) after treatment with a medicine called " clomifene citrate " which is used during assisted reproductive technology procedures ( procedures to help a woman become pregnant ). this medicine can be used alone or together with another medicine , called " luteinising hormone " or in combination with a
do not use ovaleap : if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the part of the brain that produces hormones ), such as large ovaries or sacs of fluids from the ovaries . ovarian cysts . unexplained vaginal bleeding . cancer in your ovaries , womb or breasts . any condition that may make normal pregnancy impossible . ovarian failure ( early menopause ). fibroid tumours of the womb , malformed reproductive organs
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , your doctor may give you this medicine for the first 7 days of your menstrual cycle . your doctor will tell you how many days of the cycle you need to take the medicine . the recommended dose is this medicine given as either 75 mg or 150 mg of this medicine every 7 to 14 days . if you weigh 37 . 5 kg or more , you should take 75 mg of
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . signs of severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 rare ( may affect up to 1 in 10 , 000 people ) cases of this type of reaction have been reported . if you notice any of the symptoms of ovarian hyper - stimulation syndrome ( ohss ), the ovaries may stop working properly and the treatment may need to be stopped
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 to 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . after first opening , this medicine may be stored for a maximum of 3 days below 25 . if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor or pharmacist . after 3 days , the cartridge must be used within 28 days or discarded . the pen cap must
what ovaleap contains - the active substance is follitropin alfa . each ml of solution for injection ( injection ) contains either : one 300 micrograms / 0 . 5 ml dose ( corresponding to 300 microlitres in 22 microlitre ) or one one follicle alfa - 2l - 3l - 4l - 5l - 6l - 7l - 8l - 9l - 10l - 11l - 15l - 20l - 25l - 30l - 40l - 50l - 45l - 60l - 100l - 90l - 33 - follit
voriconazole accord is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults , adolescents and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by Aspergillus sp .) and candidaemia ( a kind of serious invasive candida sp .) in non - neutropenic patients ( patients with abnormally low white blood cells count due to the presence of the fungus ) to treat fluconazole ( another antibacterial medicine to treat serious fungal infections caused by sced
do not take voriconazole accord : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking any other medicines . this includes herbal medicines and medicines obtained without a prescription . in particular , tell your doctor or pharmacist if you have any questions about the medicines you are taking , or if they have been recently taken or might be taken again . in addition , some of the medicines mentioned below have been stopped or are not suitable for you while you are being treated . do not stop v
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this will be given as 40 mg twice a day for the first 24 hours . the dose may be increased to 400 mg two times a day ( for 12 hours ) and then increased to 200 mg once every 12 hours for 24 hours and then up to 100 mg once daily . depending on how you respond to treatment , your doctor may increase your dose to
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , they are usually mild to moderate . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). other side effects very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura , visual
what voriconazole accord contains - the active substance is vorinazole . each film - coated tablet contains 50 mg ( as film- coated tablets ). - the other ingredients are : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose ( e464 ), titanium dioxide ( e171 ), lactosemonohydrate and triacetin . the film - coating contains sunset yellow fcf ( e110 ) and sunset orange fcf (" e110 ") colour . what vor
mvabea is a vaccine to protect you against ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age and older who are at high risk of getting ebola ( as a 2 - dose course of vaccinations ). the active substances in this vaccine are the zaire ebolavirus and filovirus . this vaccine works by stopping the multiplication of the whole ebolavirus in your body . it also gives you ebolairus disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of the following vaccinations : zabden
follow carefully all instructions given to you by your doctor , pharmacist or nurse . you should not receive the vaccine : if you have had a severe allergic reaction to any ingredient contained in the vaccine ( see section 6 . warnings and precautions talk to your doctor or nurse before you are given mvabea ): if you know that you have a severe allergy reaction to an antibiotic called ' gentamicin ', the vaccine may not fully protect all persons who are vaccinated . if this applies to you , tell your doctor straight away . if you are not sure if any of the information in this leaflet is true or not , talk to
your doctor , nurse or pharmacist will give you the vaccine by injection into a muscle ( intramuscular injection ) in the upper arm or thigh or into a blood vessel . the first dose of vaccination will be given with zabdeno vaccine 8 weeks later . the second vaccination with mvabea yellow cap vial may be given at least 8 weeks after the first . if you have the impression that the effect of the first vaccine is too strong or too weak , talk to your doctor . children and adolescents there is no information on the effects of the second vaccine . other types of vaccine : primary vaccination first vaccination
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth and swelling at the site of the injection very tired muscle ache joint pain common : may affect up to 1 in every 10 people : feeling sick ( vomiting ) itching at the place where the injection is given uncommon : may effect up to1 in every 100 people : redness , skin hardness at the area where thejection is given generalised itching other side effects reported in children and adolescents aged 1 to 17
what mvabea contains the active substance is zaire ebolavirus 29 produced by recombinant dna technology in tai forest ebolavirus nucleoprotein marburg at a concentration of 0 . 7 to 108 μg / ml in chicken embryo embryo fibroblast cells . the other ingredients of this vaccine are trace residues of gentamicin , sodium chloride , trometamol , and water for injections . hydrochloric acid ( for ph adjustment ) is included in the suspension as well as in the reconstituted portion of the vaccine as a suspension in a single - dose glass vial with
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronat can also be used if you have a raised calcium level in your blood due to a tumour that has been lost from your bones . this helps to stop the bones from getting weaker .
do not take bondronat : if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in cancer - related conditions . if you develop onj , stopping treatment may be necessary . onj is a painful condition that can be difficult to treat . therefore , you should be carefully checked by your doctor before you start taking this medicine . some precautions should be taken
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . patients with cancer the recommended dose is one infusion into your vein once a week . your doctor will carry out regular blood tests while you are being treated with bondronat . the dose of this medicine depends on your illness . if you have breast cancer that has spread to your bones , it may take about 3 weeks ( 3 - 4 weeks ) for an infusion in your vein . this usually takes about 15 minutes . in case of a raised calcium level in your blood , your doctor may reduce the dose to
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect less than 1 in 10 , 000 persons ) pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc to 8ºc unless dilution has taken place in controlled and validated aseptic conditions . your healthcare professional will ensure that this medicine is used correctly and not
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion ( equivalent to 2 mg ibondronic acid ). - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water and water for injections . what bondsronat looks like and contents of the pack this medicine is a clear , colourless solution . it is supplied in packs containing 1 or 2 vials with a bromobutyl rubber stopper . not all pack sizes may be marketed .
what zeposia is and what it is used for it is a medicine that is used to treat adults with relapsing remitting multiple sclerosis ( rrms ), a type of active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking , and problems with vision and balance . how it works rrls is a disease in which the body attacks its own immune system and hinders the body ' s defences . white blood cells are important as they help to protect the nerves and brain , and in particular the spinal cord and nerves . these can cause symptoms such as numb
do not take zeposia : if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severely weakened immune system ( e . g . a heart attack , angina , stroke , mini - stroke or transient ischemic attack ( tia ) warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have severe heart failure within the last 6 months you have irregular or abnormal heartbeats ( arrhythmia ) your heart is not working properly after treatment you have or have had severe infection such as
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need based on your heart rate . you will be given a ' treatment initiation pack ' for the first 4 days of treatment . the recommended starting dose is 4 capsules of 0 . 23 mg ozanimod once a day . this will be gradually increased to 1 capsule in the morning and 4 capsules in the evening . depending on how you respond to treatment , your doctor may increase your dose to a maximum of 3 capsules of
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): - slow heart rate - urinary tract infection - raised blood pressure ( seen uncommonly in up to 1 in 100 people ) - allergic reaction . the signs may include a rash . other possible side effects are listed below : common : - side effects with frequency not known ( cannot be estimated from the available data ): - infections of the nose or nostrils , nasal cavity , mouth , throat ( ph
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . if you notice any damage or signs of tampering to the pack , tell your pharmacist .
what zeposia contains - the active substance is ozanimod . each capsule contains 0 . 23 mg of zanimod ( as hydrochloride ). - the other ingredients ( excipients ) are microcrystalline cellulose ( e460 ), silica , colloidal anhydrous ( e551 ), croscarmellose sodium ( e468 ), magnesium stearate ( e470b ). - capsule shell : 0 . 03 mg of gelatin , titanium dioxide ( e171 ), yellow iron oxide , black iron oxide ( e172 ) ( 0 . 46 mg / ml ). - printing ink : gelatin ,
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide , and vilanterol . fluticastonefuroate belongs to a group of medicines called corticosteroids . these are steroids that work in different ways to help your body ' s immune system fight back against the effects of the chemical ( eosinophilia ) in your airways . vilterol is a substance produced by recombinant dna technology ( rdna ) in the body called bronchodilators . the active substances in temy
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given temybrexta . if you have asthma , your doctor may need to lower your dose . this is particularly important if you suffer from asthma , heart problems , high blood pressure , liver problems , tuberculosis ( tb ) of the lung , or any long standing or untreated infections . if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . this medicine should be used every day for 24 hours . try to use temybric ellipta at the same time each day . swallow the capsules whole with a glass of water . do not chew , crush or split the capsules . you may find it easier to open and swallow them . it is important that you continue with this medicine until your doctor tells you otherwise . if you do not feel better after 24 hours , consult your doctor . if
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) ( copd ) the most common side effect of temybric ellipta is symptoms of a lung infection such as fever , chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore or raised patches in the mouth or throat caused by a fungal infection ( candidiasis )
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose ( the dose leaving the mouthpiece ) corresponds to 92 micrograms of the two active substances . - the combined dose ( mg ) is as follows : one inhalation ( dose leaving your mouthpiece ), one dose ( 0 . 5 ml ) and one injection ( 1 ml ) of the other active substances ( excipients ). - the other ingredient ( s ) are lactose monohydrate ( see section 2 under ' temy
zinforo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues below the skin . it is used in adults to treat an infection of the lungs called ' pneumonia '. how it works zin foro works by killing certain bacteria that cause serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( e . g . penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before taking zin foro . tell your doctor if : you have kidney problems . you have a history of seizures ( convulsions ). you have ever had or might now have any non - severe
always use zinforo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults the recommended dose is 600 mg once a day for 12 weeks . your doctor may increase your dose to 600 mg every 8 weeks if you get some infections . it may be up to 8 to 12 weeks depending on how you respond to treatment . it is given as a drip into a vein ( intravenously ) over a period of 5 to 60 minutes . if you weigh 120 kg or more , you may receive an increased dose . the duration of treatment is 5 to 14
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , or swallowing or breathing problems . these could be signs of a severe allergic reaction ( anaphylaxis ). diarrhoea , stool , blood or mucus may be present . treatment with zinforo may be stopped or medicines stopped . slow bowel movement may affect up to 1 in 10 people a blood test called a ' coombs test ' will
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains - the active substance is ceftaroline fosamil . - the other ingredients are arginine and water for injections ( see section 2 ). what zzinforo looks like and contents of the pack zincforo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neurological pain : pregabalin pumpfizer is used for the treatment of long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neurological pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles , and may be life - threatening or fatal . peripheral
do not take pregabalin pfizer : - if you are allergic to pregaabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking any of these medicines . some patients who have taken some of the active substance in the manufacturing process have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience a manifestation of these reactions , you should contact your doctor immediately . the following have been reported in patients taking preg
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer should be used for the treatment of peripheral and central neuropathic pain , epilepsy and generalised anxiety disorder in adults . the recommended dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on how you respond to the medicine . you should swallow the capsule whole with a glass of water . you can crush the capsule and give it to your child as an injection in the morning or in the evening . children and adolescents do not give
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . common : increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance , fall , dry mouth , const
what pregabalin pfizer contains - the active substance is pregaabalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg , or 300 mg of pregon . - the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica ( e551 ). - the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1520 ), potassium hyd
xadago is a medicine that contains the active substance safinamide . it works by increasing the levels of dopamine in the brain . dopamine is a chemical that is involved in movement and is important for the brain to function normally . in parkinson ' s disease , changes in the amount of dopamine produced occur in the body . these changes can lead to sudden swings in the ability of people to move and difficulties moving . xadago can be used alone or in combination with the medicine levodopa or other medicines used to treat the condition .
do not take xadago if : you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid and tranylcypromine ( for treatment of parkinson ' s disease or depression ). pethidine ( a strong pain killer ) ( see section 7 " warnings and precautions "). if any of these apply to you , tell
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . xadago is available in two strengths : 50 mg and 100 mg . the recommended dose is one tablet taken by mouth once a day . your doctor will prescribe the strength that is right for you . if you have moderately reduced liver function , your doctor may prescribe the lower dose of 50 mg . take your tablet at about the same time each day . take it with or without food . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet before swallowing . x
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis : very high blood pressure may lead to collapse ( neuroleptic malignant syndrome ). signs may include confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness and hallucinations ( hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa and other medicines used to treat the condition : common ( may affect up to 1 in 10 people ): insomnia
what xadago contains - the active substance is safinamide . each 50 mg or 100 mg film - coated tablet contains a substance called methansulfonate . - the other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ) what xadadago looks like and contents of the pack xADago 50 mg are white , round , biconcave film -
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body . zytiga lowers testosterone ( androgen deprivation therapy ) in men when prostate cancer has become resistant to treatment with another medicine that suppresses the level of testosterone in the blood , prednisone . prednisolone is used in adults to treat high blood pressure in the body because it reduces the amount of fluid retention in your blood .
do not take zytiga if : you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). you are pregnant or breast - feeding . warnings and precautions talk to your doctor or pharmacist before you are given this medicine : if you have severe liver damage or prostate cancer . this medicine should not be given to children under the age of 18 years . if any of these apply to you , do not take this medicine and tell your doctor as soon as possible . if you are taking this medicine for the treatment of liver problems such as high blood pressure or heart failure
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . your doctor will tell you how many tablets of this medicine to take . this medicine is for oral use . swallow the tablets whole with a glass of water . you can take zytiga with or without food . it is best to take the tablets by mouth at the same time each day . do not crush , chew or break the tablets as this may affect how well they work for you . if you have the impression that the effect of z
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : - muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may be signs that the level of potassium in your blood is low . your doctor may need to increase your dose of potassium . other side effects may include : very common ( may affect more than 1 in 10 people ): - fluid in your legs or feet ( signs of low blood potassium or liver function test ). - high blood pressure . - urinary tract infection . - diarrhoea .
what zytiga contains - the active substance is abiraterone acetate . each tablet contains nominally 250 mg abdominalateroneacetate . - the other ingredients are : - tablet core : microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " important information about some of the ingredients in this medicine " for further information on the contents of this medicine . what ztiga looks like and contents of the pack - z
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease . paediatric non - infectious uveitis . the active ingredient in hefiya , addalimumab , is a monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the body ) and works by blocking the activity of a specific protein called tumour necrosis factor ( tnfα ).
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your child ' s doctor , pharmacist or nurse before taking this medicine if : your child has a severe infection , including tuberculosis ( sepsis ), blood poisoning or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems . your child may have moderate or severe heart failure or have a serious heart condition . allergic reaction allergic reactions may include symptoms such as chest tight
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . the dose may be increased to 20 mg , 40 mg , 20 mg or 40 mg depending on your condition . polyarticular juvenile idiopathic arthritis age and body weight how much and how often to take ? notes children and adolescents from 2 years of age weighing 30 kg or more 40 mg every other week starting from 2 to 10 kg . thereafter , your doctor may increase your dose to 30 mg or 20 mg every week . enthes
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur up to 4 months after the last hefiya injection . tell your doctor straight away if you notice any of the following : signs of allergic reaction such as heart failure , severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath or swelling of the feet . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a single period of up to 14 days . once removed from the refrigerator for room temperature storage , you may take his / her solution back to your refrigerator and use it within 14 days or dispose of it .
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adlimumab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol ( e421 ), polysorbate 80 ( e433 ), hydrochloric acid and sodium hydroxide and water for injections ( see section 2 " important information about some of the ingredients of this medicine "). what hefaya looks like and contents of the pack hafiya 20 mg solution for injection ( injection ) in pre
the active substance in ritemvia is called rituximab . this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". by sticking to the target of the target protein " b lymphocyte " it helps to stop the cell from growing and dividing . this helps the body to produce its own protection ( antibodies ) against the growth and spread of this type of cell . your doctor will test your body for this and may decide to change the dose of your medicine or to stop it from working . r
do not take ritemvia : if you are allergic to rituximab , other proteins that are derived from the needles of yew trees , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection with a weak immune system . if you suffer from severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children below the age of 6 years because it has not been studied in this age group . there is limited information on the safety of this
you will be given ritemvia under the supervision of a doctor experienced in the use of this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may lower your dose or stop your treatment temporarily . your doctor will calculate your dose based on your body weight and will tell you how many tablets you will need to take each ritemvia administration . when you first start using rithvia , you will first be given other medicines ( pre - medication ) to reduce the risk of side effects . your
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each vial of powder for concentrate contains 10 mg / ml ( 4 . 0 mg ) of rituuximb . - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemv looks like and contents of the pack ritemva is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth and spread of cancer cells . capecitabrine teva is a type of medicine known as a cytokostatic medicine . it is an active anti - cancer medicine that does not kill or slow down the growth of your own cells . furthermore it is used to treat the following tumours : colon , rectal , gastric , or breast cancers . in these tumours , the removal of the tumour by surgery is usually not necessary . in this case , capecitaban teva may be used alone or
do not take capecitabine teva - if you are allergic to cape citabine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : - have severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) - are pregnant - have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the recommended dose of cape citabine teva is based on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body square area taken once daily . this is equivalent to a daily dose of body weight of 64 kg and height of 1 . 64 m² taken once
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you get any of these symptoms : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movements each day . - if you vomit more than once in a 24 - hour time period , or if you lose your appetite . stomatitis ( pain , redness , swelling or sores in your mouth and / or throat ). hand and foot skin - reaction : pain , swelling and redness or tingling of hands
what capecitabine teva contains - the active substance is capecabine . each film - coated tablet contains 150 milligrams ( mg ). - the other ingredients ( excipients ) are lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate ( e470b ), macrogol 400 , talc ( e553b ) ( partially hydrolysed ) ( e507b ). - printing ink : shellac , nettle ( e904b ), nettles ( e1203b ), talc , e551b
silodosin recordati is a medicine that belongs to a group of medicines called alpha1a - adrenoreceptor blockers , which are used to block signals to the prostate , bladder and urethra . by blocking these signals , it allows smooth muscle in these tissues to relax and your symptoms go away . your doctor will explain to you why this medicine has been prescribed for you . the active substance in this medicine is also used to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder
do not use silodosin recordati - if you are allergic to siliodosin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . during eye surgery , you may experience cloudiness of the lens ( cataract surgery ) in the back of your eye 26 during the first few hours after you have been given the dose . your doctor may advise you to take other precautions , including medicine and surgical techniques , while you are being treated . if any of these apply to you , tell your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of silodosin recordati is 8 mg once a day . patients with kidney problems if you have moderate kidney problems , your doctor may prescribe a lower dose . your doctor will prescribe the dose that is right for you . swallow the capsule whole with a glass of water . do not chew , crush or split the capsule . for patients with this type of kidney problems the dose may need to be adjusted by your doctor . use in children and adolescents for this purpose sil
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives . the most common side effect of silodosin recordati is dizziness . if you experience dizziness and / or occasionally fainting , you may feel weak or dizzy . if the symptoms of dizziness are severe , you should contact your doctor straightaway ( see also information under the heading " warnings and precautions "). you should also tell your doctor or pharmacist if you are having a cataract
what silodosin recordati contains - the active substance is silodusin . each capsule contains 8 mg of siliodosin . - the other ingredients are : capsule content : mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). capsule shell : white , opaque , hard gelatin capsules , with a diameter of 4 mm . capsule contents : silodosein ( ( ( e422 ), aluminium ( e553b ), black iron oxide ( e172 ). printing ink : shellac , maize starch , soybean ( e904 ),
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzealmono blocks the effect of angiotenin ii so that the blood vessels relax , and your blood blood pressure is lowered . talk to your doctor or pharmacist if you are not sure about any of the benefits of this medicine to you . what is essential hypertension ( high blood pressure ) ? ' essential ' means that the highblood pressure is not caused by any other condition
do not take kinzalmono if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not take this medicine and talk to your doctor , pharmacist or nurse before taking it . if you ( or your child ( 3 years of age or older ) are pregnant , think you may be pregnant , or are planning to have a baby ) are breast - feeding ( see pregnancy section ) have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets can be taken with or without food . it is important that you take kinzalmono every day until your doctor tells you otherwise . your doctor will tell you how many tablets to take and how long you should continue to take it . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis ( often called " blood poisoning "), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other possible side effects of kinzalmono common side effects ( affects more than 1 user in 10 ): low blood pressure ( hypotension )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect from moisture . remove your kinzalmono tablet from the blister only directly prior to intake .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate in the tablet core and in the film - coating ( see end of section 2 for important information about some of the ingredients of this medicine ). what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round , flat , biconvex tablets . kinz
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology ( rdna ). it contains the active substance lonoctocog alfa . afstylfa is used to treat and prevent bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ), i . e ., blood clotting that does not normally clot . patients with an increased tendency to bleed have been shown to have been more likely to have this problem when they were growing up . if you have been told that you have not been properly trained with factor v
do not use afstyla : - if you have ever had an allergic reaction to anticholinergics . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : - are allergic to hamster proteins 46 - are breast - feeding . you should not breast - feed while you are being treated . if you are not sure if any of the above applies to you , ask your doctor or pharmacist . do not stop your treatment diary unless your doctor tells you to . you may be more likely to experience allergic ( hypersensitivity ) reactions when you are treated with afst
your treatment will be overseen by a doctor experienced in the care of patients with blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the dose of afstyla you receive will depend on the duration of treatment , the severity of your disease the site and location of the bleeding your clinical condition . reconstitution and administration general instructions the powder and the solvent ( liquid ) must be reconstituted before use in order to avoid formation of aseptic conditions . if you have not been trained in this , your doctor may
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash , tightness of the chest , difficulty in breathing , wheezing ), low blood pressure and dizziness ( anaphylaxis ). bleeding has been reported in patients treated with factor viii medicines ( inhibitor antibodies ) ( see section 2 " warnings and precautions "). very common ( may affect more than 1 in 10 people ) patients who have received previous treatment with factor iii ( more than 150 days of treatment ) and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 25 hours at 2 to 3 , unless dilution has taken place in controlled and validated aseptic
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 ml ) of solution for injection . after reconstitution , one ml of solution contains 200 iu loroctocag alfa ( corresponding to 1000 iu / ml ). the other ingredients are : powder : water for injections 1 vial of powder . solvent : solvent : polysorbate 80 , calcium chloride dihydrate , sodium chloride 2 ml solution for injections . powder : white or slightly yellow powder with friable mass . the reconstituted solution contains 250
what praxbind is and what it is used for the active substance in this medicine , idarucizumab , is a recombal agent . it dissociates from dabigatran ( pradaxa ), which is a blood thinner medicine used to prevent blood clot formation . when used in combination with other anticoagulants , it reduces the need for blood clots to form , thus making it easier for blood to be pumped around the body . what the effect is when used alone , it is unlikely that you will be able to rapidly trap dabigatheran . what prax bind is used
do not take praxbind : if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( hfi ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . serious adverse reactions have been reported with the use of the active substance dabigatran . other medicines may increase the risk of blood clots ( see section " other medicines and the drug you are taking " for a list of medicines you need to take before and during your treatment with this medicine ). dabig
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg film - coated tablet of 2 . 5 mg dabigatran per day to be taken orally with or without food . you should swallow the tablet whole with a drink of water . this medicine can be used for up to 5 days . your doctor will give you this medicine as an injection into a vein . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . your treatment will be overseen by a doctor experienced in
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ) and polysorbate 20 ( e433 ). - the solvent is water for injections ( see section 2 under " important information about some of the ingredients of Praxbind "). what it looks like and contents of the pack the clear to slightly opalescent , colourless to slightly yellow solution is supplied in a clear glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . - in children and adolescents ( 12 years of age and older ) - in adult patients whose disease has not responded to radiotherapy ( concomitant phase of treatment ) or to monotherapy phase oftreatment ( phase 3 ). - in patients with malignant glioma , such as gliOBlastoma multipurpose or anaplastic astrocytoma
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if certain kinds of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells help your body with fighting infection when proper blood clotting is not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and during treatment . your doctor may decide to temporarily or permanently stop the treatment if you experience nausea or vomiting . patients with newly - diagnosed glioblastoma multiforme treatment is divided into two
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures ( fits or convulsions ), fever , chills and severe headache , stop temomedac treatment and contact your doctor immediately . there may be a reduction in certain kinds of blood cells . this can cause increased bruising or bleeding , anaemia ( reduced number of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived and can lead to anaemia
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after first opening , the capsules should be used within 30 days . if you notice any change in the appearance of the capsules , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide ( as mesilate ). each capsule ( desilate ) contains 5 milligrams of temozolsomide . each capsule [ s ] ( 200 mg ] ( 400 mg ) ( 2 tablets ) ( 20 tablets ) contains 20 milligram ( millilitre ( milliliter ) temozolaomide and each capsule ' s ( s ) ( 100 mg ) contains 100 milliurams ( millipliter ). each tablet [ s ) contains 180 milliugram ( milliuiter ) of tem ozolomides . each
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis will only help you to obtain a hard erect penis if you have agreed with your partner that it would be best for you to engage in sexual activity with someone who is willing to help you get a hard erection . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors , which work by reducing the activity of the blood vessels in your penis . this will help your penis stay hard and erectile
do not take cialis if : you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) you are taking any form of organic nitrate or nitric oxide donors ( such as amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor or pharmacist before you are given this medicine . taking nitrate may increase the risk of serious heart disease . you have recently had a heart attack within the last 90 days . you recently had or might now have a stroke within
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . the tablets can be taken with or without food . the usual starting dose is between 5 mg and 2 . 5 mg per day . your doctor will tell you how many tablets to take . if you have the impression that the effect is too strong or too weak , talk to your doctor , pharmacist or nurse . do not change your dose unless your doctor tells you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions including rashes ( frequency not known ) and chest pain have been reported in patients taking nitrates . the frequency is not known ( frequency cannot be estimated from the available data ). priapsim may cause a prolonged and possibly painful erection . stop taking cialis and get an erection straight away ( see section 4 " warnings and precautions "). contact your doctor immediately if you experience sudden loss of vision . this is not of the frequency listed above . other side effects very common ( may
what cialis contains - the active substance is tadalafil . each 2 . 5 mg film - coated tablet contains a tablet ( tablet ) that contains a desiccant to reduce the acidity of the tablet . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : hypromellose , triacetin , titanium dioxide , iron oxide yellow ( e172 ), iron oxide red ( e
enyglid is an oral antidiabetic medicine containing repaglinide , which helps your pancreas make better use of insulin when your blood sugar is high ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin to control the sugar in your body . the insulin that your body makes does not work as well as it should . you must continue to follow the advice about diet and exercise given to you by your doctor , pharmacist or nurse . your doctor will tell you how many treatments you need and how long you should continue with treatment . diet , exercise and weight reduction can help
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have a severe liver disease . you are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). you have liver problems . you have moderate liver 28 disease . see section 2 . if any of these apply to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . try to take your daily dose at about the same time each day . this will help you remember to take it . however , if it is almost time for your next dose , skip the dose you missed and go back to your regular schedule . do not take a double dose to make up for a forgotten dose . if you
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia ( the most common side effect of enyglid ) is very rare ( may affect up to 1 in 10 , 000 people ) but can be serious and needs immediate medical attention : if you experience symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating , anaphylactic reaction ( see section 2 ). other side effects include : very common ( affects more than 1 user in 10 ): stomach pain diarrhoea rare ( affects 1 to 1 users in 1 , 000 ): acute coronary syndrome
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) only in 1 mg tablet only in 2 mg tablets only in 3 mg tablets which are white , round and biconvex with bevelled edges . only
azacitidine mylan contains an anti - cancer agent called azapitidine . what azacitrix mylan is used for the purpose is to treat adults with certain types of myelodysplastic syndromes ( mds ). it is used in adults to treat chronic myelomonocytic leukaemia ( cmml ) and acute myeloid leukemia ( aml ). mds is a group of diseases that affect the bone marrow , where normal blood cell production is not restored . how it works azacitonidine melan works by blocking the growth of cancer cells in the body .
do not take azacitidine mylan - if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have advanced liver cancer . your doctor may want to monitor you more closely . you should tell your doctor if you : have decreased counts of platelets , red or white blood cells . have kidney disease or liver disease . have a heart condition ( such as heart attack or lung disease ). have blood test results that show that your liver is working properly . children and adolescents the
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is one 75 mg tablet of this medicine per day . your doctor will work out your dose based on your height and weight . you will usually be given one tablet once a day . if you miss a dose , take it as soon as you remember and then take your next dose at its regular time . do not take a double dose to make up for a forgotten dose . how much to take the usual starting dose is two tablets each day . this " treatment cycle " will be repeated every 4 to 6 weeks
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( e . g . abdominal bloating and easy bruising ), which may be symptoms of liver failure , swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( symptoms of kidney failure ). a fever may be a sign of an infection with low levels of white blood cells . chest pain or short
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . after reconstitution , the medicine must be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 1 hour at 2 to 8 , unless dilution has taken place in controlled and
what azacitidine mylan contains powder : one vial contains 100 milligrams ( millilitres ) ( 0 . 5 ml ) of azaitidine . after reconstitution , 4 ml of water for injections is sufficient . the reconstituted suspension contains 25 mg / ml . the other ingredient ( s ) ( excipients ) ( see section 2 ) ( contains potassium ) and is mannitol ( e421 ) in the form of e421 ( e433 ) ( e507 ) ( in the colourless to pale yellow part of the powder . see section 4 ) for further information .
duotrav eye drop solution contains a combination of two active substances , travoprost and timolol in one drop . travostrost is a prostaglandin analogue ( a natural analogue in the eye ) that helps to reduce the amount of fluid in and out of the eye when it is put in by soft contact lenses . the other active ingredient , travdoprost , is a beta blocker that reduces fluid within the eye and thus reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav : if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). if you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( e . g . wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever , a slow heartbeat ), heart failure ( a disorder of heart rhythm , irregular heartbeat ), or if your eye becomes cloudy . warnings and precautions talk to your doctor or pharmacist before taking duot
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye or eyes once a day . do not use duotrav in your eyes unless your doctor tells you to . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how to use your eyes your doctor will tell you how many drops to use and how often to use them . the recommended starting dose is 1 drop in each affected eye each day , followed by 3 drops in each
like all medicines , this medicine can cause side effects , although not everybody gets them . if any of the effects gets serious , stop using duotrav and talk to your doctor or pharmacist immediately . very common side effects ( may affect more than 1 in 10 people ) effects of the eye eye redness ( frequency not known ( cannot be estimated from the available data ) ( frequency is common ) effect of the drops on the eye surface inflammation or surface damage may cause eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms may include eye irritation , burning or stinging .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . after first opening , use within 4 weeks to prevent infections .
what duotrav contains - the active substances are travoprost and timolol . each ml contains 40 micrograms ( 10 microlitres ). - the other ingredients ( excipients ) are propylene glycol , polyoxyethylene hydrogenated castor oil 40 %, boric acid , sodium chloride , sodium hydroxide , hydrochloric acid and purified water . - the solvent is water for injections . - after reconstitution of the reconstituted product , the active substance is ethanol , which is a clear , colourless solution in a 2 . 5 ml plastic bottle with a screw
nplate ' s active ingredient is romiplostim . it is a protein that is used to reduce low platelet counts caused by the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body ' s immune system does not produce enough platelets . platelets are important in your blood because they help to prevent blood clots from forming and so reduce the chances of you having a severe , life - threatening , or even fatal , reaction . very lowplatelet counts can lead to bruising and serious bleeding . nplate is used in adults
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before taking nplate : if you have a low blood platelet count ( thrombocytopenia ). if this applies to you , your doctor may reduce your dose of nplate or temporarily stop it . your doctor will monitor your platelet counts to avoid blood clots . if you suffer from blood clotting , please tell your doctor .
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( from 1 to 17 years of age ) the recommended dose of nplate is one injection once a day . nplate should be injected every day . your doctor will check your platelet counts regularly . you will have regular blood samples taken to count your platelets . the number of platelets in your blood will depend on how much you weigh and how often you have to take nplate . if you have any physical symptoms , please inform your doctor as soon as possible . your blood plate
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : very common ( may affect more than 1 in 10 people ): headache , allergic reaction , upper respiratory tract infection ( common ) ( very common ) and may affect up to 1 in every 10 people : bone marrow disorder ( uncommon ) increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness or the skin ( flushing ), blood clot in a lung artery ( pulmonary embolism ),
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after first opening : do not store above 30 . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . nplate 125 mg powder for solution for injection each vial contains 230 mg ( 3 . 0 milligrams ). - the other ingredients ( excipients ) are : nplate 250 mg : each ml of solution contains 375 mg ( 6 . 5 milligram ) romipliplostime . each vials of 0 . 25 ml solution contains 125 mg ( 5 . 0milligrams ) romplostim and 500 mg ( 10 . 1 millilitres ). nplate is available in vials containing 250 mg , 375 mg or 500 mg
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of the lungs . using this medicine will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler : - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before using this medicine if you : - have kidney problems - have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). your doctor may decide to reduce the dose or stop treatment . if you think any of these apply to you , tell your doctor or pharmacist immediately . - have tightness of the chest , coughing , wheezing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to inhale the recommended dose is one inhalation once a day . you should inhale this medicine every day for 24 hours at about the same time each day . your doctor may increase your dose to 75 inhalations per day depending on how you respond to this medicine . this medicine is available as an inhaler and capsules ( in blisters ) containing the medicine as inhalation powder . the capsules should be swallowed whole with a glass of water . do not
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( 3 . 5 mg ) glycoprroniumbromide and 50 microgram ( 5 . 0 milligrams ( 10 . 5 millilitres ), which is equivalent to a delivered dose . each delivered dose provides a deliverable dose ( equivalent to 12 . 5 microgram , 5 . 1 millilitre , 3 . 4 millilitr ), which will deliver the delivered dose ( 23 . 7 microgram ), equivalent to 44 microgram, 5 . 5
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are important for calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms ( for example , schizophrenia ) hearing , seeing things which are not there ( mistaken beliefs ), incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious or tense . the signs of bipolar disorder
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adsasuve ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortness of breath 25 you have neuroleptic malignant syndrome ( nms ). these are symptoms of antipsychotic medicines .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day . your doctor may increase your dose every 2 weeks to 4 . 5 mg depending on your condition . adasuve is for oral use . you should swallow the tablet whole with a glass of water . do not chew , crush or split the tablet as this may cause your condition to get worse . it is best to take the tablet with food , preferably at the same time each day . it should be taken with or just after a meal . ad
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking adasuve and see a doctor straight away if you notice any of the following serious side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , irritating your airways ( asthma or copd ). - light - headedness or fainting . these may be signs that your blood pressure is getting too high . - worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . other side effects include :
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . if you notice any visible signs of physical damage , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
always use adasuve exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . each single - dose inhaler delivers 5 mg of loxapine in the morning and delivers 4 . 5 mg in the evening . do not use more than your doctor tells you to use . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
azacitidine betapharm contains the active substance aminotecan . azacitonidinebetapharm is an anti - cancer agent which belongs to a group of medicines called ' anti - metabolites '. what is it used for ? it is used to treat adults with certain types of myelodysplastic syndromes ( mds ). these include chronic myelomonocytic leukaemia ( cmml ) and acute myeloid leukemia ( aml ). these are diseases that affect the bone marrow , where normal blood cell production is not restored . how it works azacitrix betaph
you must not be given azacitidine betapharm - if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). if you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you should tell your doctor if : you have decreased counts of platelets , red or white blood cells . you have kidney disease . your doctor may want to monitor you more closely . have liver disease . have a heart condition ( such as heart attack ). have lung disease . blood test your doctor will do blood tests
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is one 75 mg tablet of this medicine per day . your doctor will work out your dose based on your height and weight . you will usually be given one tablet once a day during the first week of your treatment cycle . the dose may be increased every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine will be injected under the skin ( subcutaneously ) on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these are symptoms of kidney failure . a fever may be a sign of an infection with low levels of white blood cells . chest pain or shortness
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and the carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . the unopened vial does not require any special temperature storage conditions . after reconstitution , the medicine must be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than
what azacitidine betapharm contains powder : one vial contains : the active substance in this medicine is azacitonidine . each ml of reconstitution contains 4 mg / ml . the other ingredients are water and water for injections . the reconstituted suspension contains a minimum of 25 mg / vial of azaccitidine . the excipients are mannitol ( e421 ) and concentrated ( see section 2 " important information about some of these ingredients "). solvent : solvent : see section 4 for further information on solvent use . water and / or injections : this medicinal product does not require
the active substance in cerdelga is eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which a substance called glucosylceramide is not removed from your body . this substance is mainly produced by the spleen , liver and bones . if you do not respond normally to the medicine , you may not be able to take it . your doctor will test your affected organs to make sure that it is working properly . this medicine will be given to you by a doctor or nurse who is experienced in the use of this medicine .
do not take cerdelga if : you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called " moderate cyp2d6 inhibitors " ( e . g . quinidine , terbinafine ) 31 or " moderatecyp3a inhibitors " such as erythromycin or itraconazole . these medicines are used to improve your body ' s ability to absorb nutrients . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor , pharmacist or nurse before taking cerdel
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet twice a day with or without food . your doctor will tell you how many tablets to take . the amount of metaboliser to take depends on how much medicine you are taking . the recommended daily dose for adults is 84 tablets . swallow the tablets whole with a glass of water . if you take more cerdelga than you should if you accidentally take too many tablets , contact a doctor or the nearest hospital straight away . take the tablet pack with you .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations ( throat irritation ) heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin h
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the sleeve after exp . store in the original package in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg of nominally adhered to the dietary recommendations for the year . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see end of section 2 under ' important information about lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution
ziehira contains the active substance in zoledronic acid hospira . it belongs to a group of substances called bisphosphonates . it is used for the treatment of adult patients with cancer . it works by slowing down the rate of bone change and preventing bone complications , e . g . fractures , from occurring in bone metastases ( spread of cancer from primary site to the bone ). it reduces the amount of calcium in the blood in adult patients where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given this medicine if any of the above apply to you . if you are not sure , talk to your doctor or pharmacist before you are given the medicine . warnings and precautions you should tell your doctor if you have or have ever had : - a kidney problem . - pain , swelling or numbness of the jaw , or a feeling of heaviness in the jaw or loosening
always use zoledronic acid hospira exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . bisphosphonates intravenously ( into a vein ) is recommended for ' iv ' administration . in order to reduce the risk of dehydration , you should drink plenty of fluids before and during treatment with this medicine ( see section 4 ). if you have a kidney problem , your doctor may prescribe a lower dose depending on the severity of your kidney problem . your doctor will discuss this with you . use in children and adolescents this medicine has not been studied in children or adolescents .
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most frequently reported side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ). low level of calcium in the blood ( uncommon ) may affect more than 1 in 100 people : pain in the mouth , teeth and / or jaw ; swelling or non - healing sores inside the mouth ; jaw discharge ; numbness or a feeling of heaviness in the jaw ; loosening of a tooth . these could be signs of bone damage
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly .
what zoledronic acid hospira contains - the active substance is zolingronic acid . each vial contains 4 mg zoledron acid ( as monohydrate ). - the other ingredients are : mannitol , sodium citrate and water for injections . what zedronic acidic hospira looks like and contents of the pack zoledic acid hospir is supplied as a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains one vial of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . this type of chemotherapy destroys nerve cells in the brain . this can lead to vomiting ( being sick ) and can be life - threatening . varuby works by killing these nerve cells . it can also cause nausea and vomiting .
do not take varuby if you : are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). are taking an herbal medicine called st john ' s wort ( hypericum performatum ). are suffering from depression or difficulty sleeping ( see section 2 " warnings and precautions "). are taking this medicine 27 have severe liver or kidney problems . are taking certain medicines containing rifampicin ( for tuberculosis or other infections ), carbamazepine ( for epilepsy and nerve pain ), phenobarbital ( used for epilepsy ), enzalutamide ( for prostate cancer ), phen
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 180 mg tablet once a day for up to 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . it is best to take the tablet at least 2 hours before or at the start of your chemotherapy cycle . your doctor may change your dose , depending on how you respond to chemotherapy and whether you experience sickness . if you have sickness , take it as soon as you remember . this medicine is for oral use . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , as appropriate treatment may be needed . other side effects include : very common : may affect more than 1 in 10 people : headache ; constipation ; feeling tired uncommon : may affects up to
what varuby contains - the active substance is rolapitant . each tablet contains 90 milligrams . - the other ingredients ( excipients ) in the tablet core are : tablet core : lactose monohydrate ( see section 2 under ' important information about lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . tablet coat : blue
what enerzair breezhaler is the active substance in this medicine is indacaterol - glycopyrronium - mometasone furoate ellipticodilators ( e . g ., inhaled through the muscles of the lungs ). ellipticudil belongs to a group of medicines called corticosteroids , which are used to reduce the swelling and irritation ( inflammation ) in the small airways in the lungs . breathing problems can occur during and after breathing and can be caused by attacks of asthma ( see section " important information about some of the active substances in this medicinal product ").
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems ( such as diabetes , high blood sugar , seizures ) - have severe kidney problems , severe liver problems , low level of potassium in your blood -
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should inhale the medicine at the same time each day . if you use more enerzair breezhaler than you should if your asthma is getting worse or if your symptoms get worse , talk to a doctor or go to the nearest hospital straight away . do not use more than your doctor tells you to use . how much to use the active substance in this medicine is called an inhaler and capsules . the medicine is contained in a
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . these may be signs of allergic reaction . other side effects other possible side effects include the following side effects : common : may affect up to 1 in every 10 people : sore throat , runny nose , sudden difficulty breathing , feeling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used immediately after first opening .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of the combined active substances , as measured by the mouthpiece of the inhaler . - the other ingredients are : - the content of the capsules is as follows : - capsule content : - each delivered dose contains 50 micromole ( 0 . 5 milligrams ) of the original substance , as calculated by the health professionals at the end of the leaflet . - each
clopidogrel acino pharma gmbh contains the active ingredient clopridogrel which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombo - occlusion ). this process is also known as reverse transcriptase ( thrombi ) and makes hardened blood vessels ( arteries ) prone to atherothrombosis
do not take clopidogrel acino pharma gmbh : - if you are allergic ( hypersensitive ) to clopridogrel or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the tablets if : - you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain - you suffer from severe liver disease . if you think any of these apply to you , or if you have any further questions on the use of this product , ask your doctor or pharmacist .
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual starting dose is one 75 mg tablet taken orally with or without food . your doctor will tell you the dose to take . if you cannot take the tablet whole , you should contact your doctor , pharmacist or the nearest hospital emergency department immediately . for minor cuts and injuries e . g ., cutting yourself , shaving , this is usually of no concern . however , if you have any further questions on the use of this product , ask
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ) rare : very rare : may affect up to 1 in 10 , 000 people not known : frequency cannot been estimated from available data contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due to rare decrease
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . this does not prevent damage of blister and film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains - the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). - the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating ( e1203 ) macrogrol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmá gmb h looks like and contents of the
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are already taking medicines called ' antiretroviral medicines '. the active substances in delstrigo are doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , which is also known as a neosinophil analogues ( nrti ) and tenofovir disoproxil , which are all known to be active substances of the virus ( aids (' acquired immune deficiency syndrome '). by stopping the virus from multiplying ,
do not take delstrigo : if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take the following medicines : carbamazepine , oxcarbazepine and phenobarbital and phenytoin ( medicines to prevent seizure ) rifampicin and rifapentine ( medicines used to treat tuberculosis ) st . john ' s wort ( hypericum perforatum , a herbal remedy used for depression and anxiety ) products containing mitotane (
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is a complete regimen of one tablet once a day . a single tablet should not be used to treat hiv infection . your doctor may prescribe a lower dose ( up to 1 tablet a day ) of certain medicines ( e . g . doravirine ). your doctor will tell you which medicines to take . taking this medicine swallow the tablet whole with a glass of water . you can take this medicine with or without food . if you take more delstr
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking delstrigo and tell your doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms such as pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( might affect up to 1 in 100 people ): nightmares , depression , anxiety , irritability ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and on the carton after exp . this medicinal product does not require any special temperature storage conditions . keep the bottle tightly closed in order to protect from moisture . after first opening of the bottle , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains - the active substances are 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ). - the other ingredients are croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl feumarate . - a coating material containing carnauba wax e903 . - printing ink : shellac , polysorbate 903 ( e1203
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression , such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant in adults , adolescents and children aged 2 years and older . antidepressant medicines should not be used alone .
do not take spravato if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). if you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ) or have recently had a heart attack . within 6 weeks of starting treatment , you may experience a temporary increase in blood pressure . this can lead to serious complications in these conditions . if any of these apply to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given sp
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the spravato nasal spray should be inhaled using the nasal spray device provided in the carton . the recommended dose is 1 spray , 2 spray devices and 3 nasal spray devices . use at least one spray device every 4 hours for at least 4 hours . you should not use more than one spray in the morning and one in the evening . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): feeling disconnected , feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity to noise , spinning sensation ( vertigo ), vomiting nausea common : may affect up to 1 in every 10 people : feeling extremely happy ( euphoria ), feeling agitated , feeling anxious , eyes , ears , sense of touch are deceived or mimicked , irritable panic attacks , change
what spravato contains - the active substance is esketamine . - each nasal spray device contains a desiccant containing eosinophilia b . each single - use nasal spray contains 28 milligrams ( mg ). - the other ingredients ( excipients ) are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections ( see section 2 " important information about some of the ingredients "). whatspravato looks like and contents of the pack spravatos is a nasal spray solution for use in children . this medicine is a clear , colourless solution
zerbboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer is caused by a change ( mutation ) in a gene responsible for producing melanoma cells . zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . allergic reactions if allergic reactions occur while you are being treated , or after you have been treated , your doctor may decide to temporarily or permanently stop your treatment . if you experience any symptoms
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 4 mg tablet once a day for up to 8 weeks . if you take more than 4 tablets a day , you may experience side effects . your doctor may lower your dose or stop your treatment . taking zelboraf at the same time each day may reduce the risk of vomiting . take the tablet before or after food . swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . if possible , take it with or without food .
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions such as swelling of the face , lips or tongue , difficulty breathing rash fainting sensation have been reported very rarely in cancer patients . if you experience any of these , tell your doctor or hospital pharmacist immediately . radiation treatment some of the side effects may be caused by radiation . in some cases , your doctor may need to reduce your dose , or temporarily stop zelbaf treatment . radiation may affect the skin , esophagus , bladder , liver , rectum , and lungs . contact your doctor immediately if
your doctor , pharmacist or nurse knows how to store zelboraf properly . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - concipitate of vial contents ). - the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks
duoplavin contains clopidogrel and acetylsalicylic acid ( asa ) and belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood which clump together during blood clotting . by preventing this clumping , the blood vessels relax and blood can be formed . if you are not careful about this , you may be at increased risk of blood clots ( atherothrombosis ) and may have to be permanently removed by your doctor . duoplavic is taken to prevent blood cl
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to other products called non - steroidal anti - inflammatory products if you suffer from painful and / or inflammatory conditions of muscles or joints if you have a medical condition ( e . g . asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ), if you currently have a risk of bleeding such as a stomach ulcer or bleeding within the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you can take duoplavin with or without food . try to take your medicine at the same time each day . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet before swallowing . if you have a risk of having a heart attack , take the tablet as soon as you remember and then take your next dose at the usual time . if it is more than 12 hours until your next scheduled dose , skip the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . if you notice any visible sign of deterioration , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
duoplavin 75 mg film - coated tablets each tablet contains 46 mg of the active substances , clopidogrel ( as acetylsalicylic acid (asa ) and 75 mg of clopridogrel as hydrogen sulphate ). the other ingredients are : - tablet core : polysorbamide ( e1203 ), acetyl salicylic acids (asa ), mannitol ( e421 ), macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see section 2 ' duoplin contains hydrogen
the active substance of simbrinza is brinzolamide . it is a substance that binds to a specific target in the body called brimonidine tartrate ( α - 2 adrenergic receptor agonists ), which helps to reduce pressure within the eye . the active substance in simbrazolamide belongs to a group of medicines called carbonic anhydrase inhibitors , which bind to a target on the surface of the retina ( the layer that lines the front part of the eye ). it is used in adult patients ( aged 18 years and older ) to treat eye conditions such as glaucoma , ocular
do not take simbrinza : if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines to treat depression or parkinson ' s disease ). if you take certain antidepressants . if you have not taken any antidepressant medicines in the past . warnings and precautions talk to your doctor , pharmacist or nurse before taking sim
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . simbrinza should only be used in the eyes . avoid touching your eyes or eyes with your hands . step 1 step 2 remove the cap and snap collar . before using the medicine , wash your fingers with soap and water . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your eyelid with a clean finger until there is a ' pocket ' between the eyelid and the coloured part of your eye . the drop will
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects of this medicine are a reaction to the medicine ( frequency not known ). signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat . contact your doctor immediately if you experience extreme tiredness or dizziness . the following side effects have been reported with simbrinza in combination with other medicines containing brinzolamide or brimonidine : common side effects ( may affect up to 1 in 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . if you use more simbrinza than you should do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each millilitre of suspension contains 10 milligrams ( mg ) of brin zolamide ( corresponding to 2 mg / ml of suspension ). each ml of solution contains a single milligram ( milliliter ) of solution for injection ( equivalent to 1 . 3 micrograms / ml ). - the other excipients are : benzalkonium chloride ( see section 2 under ' important information about some of the ingredients of the suspension ') - the ingredients in the suspension are propylene gly
filgrastim ratiopharm is a combination of two active substances , which contain a protein called escherichia coli . it belongs to a group of proteins called cytokines , and is very similar to a natural protein ( granulocyte - colony stimulating factor [ gf - csf ]) produced by your own body but is made specifically for you by your doctor , nurse or pharmacist . filgrasterim works by encouraging the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . your doctor has prescribed filgrast
you must not be given filgrastim ratiopharm : - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you may get some of the following side effects : sickle cell disease 57 feeling left upper abdominal pain or pain at the tip of your shoulder ( this may be a symptom of a spleen disorder ) tell your doctor straight away if you get any of these side effects . regular blood tests before and during treatment with filgr
filgrastim ratiopharm will be given to you by a doctor or nurse who is specialised in the care of patients who are not able to take the medicine . your doctor will explain to you how to prepare and give it to you . if you are not sure , talk to your doctor , pharmacist , or nurse before you are given this medicine . how often and for how long you will be treated your doctor may decide to delay or interrupt your treatment depending on your condition and on how well your disease is responding to treatment . in some disease types , the usual starting dose is one tablet of filgrast
you must not be given filgrastim ratiopharm : if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder . see section 4 . possible side effects . your doctor will carry out regular blood tests before and during treatment . the number of neutrophils ( a type of white blood cells ) in your blood will depend on how well your treatment is working and on how you respond to treatment . children and adolescents this medicine is not recommended for use in children or adolescents under the age of 18 years . other medicines
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . after first opening : store in a refrigerator ( 2 to 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . keep out of direct sunlight and direct contact with the dilution pump ( for example , if it is cloudy or there are particles in it ). medicines should not be disposed of via wastewater or household waste . ask your
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of concentrate for solution for infusion contains 60 mg of filgrasim . - each pre - filled syringe containing 30 ml of solution for injection contains 30 micrograms ( 1 . 5 millilitres ). - each prefilled syringe contains 30 million international units ( iu ) ( 4 . 0 milligrams ) ( 5 milligram ) ( 6 . 1 milliliter ) ( 8 . 0 microgram ) ( 9 . 1 microgram ). - the other ingredients are : sodium hydroxide
what riluzole zentiva is and what it does it is a medicine that contains the active substance rosuvastavir . it is used to treat adults with amyotrophic lateral sclerosis ( amy ), a form of motor neurone disease in which the nerve cells in the muscles are damaged , leading to weakness , muscle waste and paralysis . this causes the destruction of nerve cells . in patients with motor neuroone disease there may be too much glutamate ( a chemical messenger ) in the brain and spinal cord . rilanuzolezentiva works by reducing the amount of glutamate that can be passed on to the
you must not be given riluzole zentiva : if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you have any liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you may experience : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick ( these may be signs that your kidneys are not working properly ). fever . a low number of white blood cells which may increase the risk of infection . children and adolescents this medicine is not recommended for use in
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken by mouth at least 12 hours before or at bedtime . if you take more riluzole zentiva than you should if you accidentally take too many tablets , contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible , show the doctor your pack of tablets . do not take a double dose to make up for a forgotten tablet . you should not take more tablets than your doctor tells you to .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ) during treatment with riluzole zentiva . this may be due to a decrease in the number of white blood cells . your doctor will take a blood sample to check for this and may adjust the dose if necessary . if you notice any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood
what riluzole zentiva contains - the active substance is rilanuzole . - the other ingredients are : - core : anhydrous dibasic calcium phosphate , micro crystalline cellulose ( e460 ) - printing ink : the following ingredients are excipients : - aspartate aminotransferase ( a type of sugar ), - talc ( e553b ), - in the tablet coating : croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). not all the ingredients may be present in this medicine . what r
emgality contains the active substance galcanezumab . this is a medicine that blocks the activity of a protein called calcitonin gene , which is involved in migraine . increased levels of cgrp in the blood can lead to an increased risk of migraine . emgality is used to treat migraine in adults , adolescents and children aged 4 years and above who have experienced at least one or more migraines before , during or shortly after their first visit to a doctor or other medical facility . your doctor has determined the frequency of migraine headache that is most common in these patients and to improve your quality of life
do not take emgality : if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease warnings and precautions serious cardiovascular diseases can occur , especially with the use of this product in patients with a history of allergic diseases . signs and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if you notice any of these reactions , you should contact your doctor immediately . these reactions may occur within 40 minutes of a serious allergic reaction . such signs and possible side effects are described in section 4 . children and adolescents
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg / m2 body surface ( subcutaneous injection ). your doctor may decide to increase or decrease the dose depending on how you respond emotionally and physically to the medicine . your doctor will tell you how many treatments you need and how long you should continue to use it . if you have the impression that the effect is too strong or too weak , talk to your doctor , pharmacist or nurse . you may need a higher or lower dose of emgally . emg
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps . other side effects tell your doctor or nurse if you notice any of the following : very common side effects ( may affect more than 1 in 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after first opening , the product may be stored for up to 7 days at room temperature ( up to 30 ) prior to use . this medicine does not require any special temperature storage conditions .
what emgality contains - the active substance is galcanezumab . one ml of each pre - filled pen contains 120 mg ( 1 mg ) galcanesumab ( as besilate ). - the other ingredients are l - histidine , l- histidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , and water for injections . what emgon looks like and contents of the pack emgonality is a solution for injection in a clear glass syringe . the solution is colourless to slightly yellow . the syringe is supplied in single - dose pens of 1 , 2
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hav ) in which the blood vessels in the liver become damaged and clogged with blood clots , which can be fatal . it has been given to you by a doctor or nurse who has been previously treated with medicines prior to a stem cell transplantation . your doctor will work out the right dose for you . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - are taking other medicines to prevent blood clots ( tissue plasminogen activator warnings ) - are using medicine to prevent bleeding ( e . g . if you have heavy bleeding after a blood transfusion or surgery ) - have problems with blood circulation - have a constant blood pressure ( see section 1 under " important information about some of the medicines you may take ")
the treatment with defitelio will be started by a doctor who has been trained in the use of stem cells transplantation . it will be given by infusion into one of your veins ( known as an ' intravenous infusion ') or drip . the duration of this treatment is 21 days . if your symptoms do not improve after this 21 day period , your doctor may decide to reduce the dose . if you have any further questions about how to use this medicine , ask your doctor or pharmacist . children and adolescents do not give this medicine to children less than 18 years of age because there is no experience in this age group
like all medicines , defitelio can cause side effects , although not everybody gets them . if any of the side effects gets serious , or if you notice any of these side effects not listed in this leaflet , please tell your doctor immediately . very common ( may affect more than 1 in 10 people ): low blood pressure . this may affect up to 1 in every 10 people . bleeding in general bleeding , including the nose bleeding , the brain bleeding , and the gut vomiting , blood bleeding from the lungs bleeding , blood in the urine , the mouth bleeding , or the skin coagulopathy ( disturbance in blood clotting
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . after reconstitution , the infusion storage should be completed 24 hours after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 2 hours at 2 - 8 unless dilution has taken place in controlled and validated aseptic conditions . the product should not be used if it
what defitelio contains - the active substance is defibrotide . each ml of solution contains 2 . 5 mg or 200 mg of reflux ( reflux ). - the other ingredients ( excipients ) are water for injections ( see end of section 2 ) and sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water to concentrate ( for injections ). see section 2 for further information about some of the ingredients of this medicine . what it looks like and contents of the pack this medicine is a concentrate for solution for infusion . each carton contains 10
daklinza contains the active ingredient daclatasvir , which is used to treat hepatitis c , an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by blocking two different proteins that are involved in this process , which are called thrombocytopenia and ciprofloxacin . when a person is given this medicine , they may also be given other medicines to help control hepatitis c infection . it is important that you also read the package leaflets for the other medicines that you will be taking . if you have any further questions on the use of daklin
do not take daklinza if : you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) you are taking by mouth the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics to treat tuberculosis ) dexamethasone ( a steroid used to treat allergic and inflammatory diseases ) medicines containing st . john ' s wort ( hypericum perforatum )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of daklinza is one 60 mg tablet once a day . do not chew or crush the tablet as this may have an unpleasant taste . your doctor will tell you how many tablets to take . if you have to take some other medicines , your doctor may tell you to take a different dose . it is very important that you continue with the instructions given to you by your doctor , pharmacist or nurse so that it is easier for you to remember to take d
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir or ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ): headache fatigue common : common : not known ( frequency cannot be estimated from the available data ): difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles some patients have experienced the following effects while being treated with both of these active substances : decrease in the number of red blood cells ( anaemia
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclaasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) ( only in 51 mg tablets ). what dak
proquad is a vaccine to protect against measles , mumps , rubella , chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce antibodies against the diseases that cause mumps and rubella . when these are given to people , they can be more likely to develop diseases caused by these viruses . proquad can be given to adults , adolescents and children from 9 years of age . national vaccination schedules contain measles caused by live viruses , which can be different from those that are normally given to children . it can also be
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have a blood disorder or type of cancer that affects the immune system ( for example , treatment with medications that weaken your immune system , e . g . low - dose corticosteroid therapy , asthma or replacement therapy ). if you suffer from a weakened immune system due to a disease ( including aids ), congenital or hereditary immunodeficiency ( immune competence ), active untreated tuberculosis , fever ( over 38 . 5
proquad is given as an injection into a muscle ( subcutaneously ) under the skin ( usually in the thigh or upper arm ). injections may be given into the muscle of the thigh area or into the upper arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be injected into the skin . this may increase the risk of bleeding or damage to the muscle . proquad is injected into a blood vessel ( intravenously ). proquad can be given to infants and children from 9 months of age and adolescents from 12 years of age . there is no experience with chickenpox or measles
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you experience signs of an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : very common ( may affect more than 1 in 100 people ): seizures ( fits ) with a fever rare ( likely to affect up to 1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ) other possible side effects of proquad are listed below . very common : may
what proquad contains - the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain , 4 . 30 mg rubella virus2 , strain 3 .00 mg varicella virus3 , merck strain ( 3 . 99 mg mrc ). - the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 and hanks ' salts ( mem , ne
jylamvo is a substance that is absorbed by the body and is an anticancer medicine which reduces unwanted reactions . it is also known as an immunosuppressive agent . by reducing the activity of the immune system , it is thought to have an anti - inflammatory effect jylimvo is used to treat rheumatic and skin diseases : - active rheumatoid arthritis with polyarthritic forms in the joints - severe juvenile idiopathic arthritis ( jia ) in adults , adolescents and children 3 years of age and older . it can be used alone or in combination with non - steroidal anti -
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe kidney impairment or a liver impairment . if you suffer from blood disorders ( e . g . bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia ). if 34 you have or have ever had a weakened immune system or a serious infection such as tuberculosis , hiv or ulcers in the stomach or intestines , or an inflammation of the mucous membrane of the mouth or mouth ulcers .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . the treatment should be initiated under the supervision of a physician experienced in the care of patients with rheumatoid arthritis , severe juvenile idiopathic arthritis and severe psoriasis . if you have severe psoriatic arthritis , your doctor may recommend that you use jylimvo as a long - term treatment . your doctor will determine the most appropriate dose for you . use in children and adolescents the recommended dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching , especially affecting your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort severe diarrhoea mouth ulcers , black or t
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the vial label and the carton after exp . store below 25 . store in the original package in order to protect from light . the medicine should be used immediately after dilution . in the event of accidental spillage , chemical and physical in - use stability has been demonstrated for 3 hours prior to administration . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each millilitre of solution contains 2 mg ( 23 mg ) of methotreate . - the other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzene ( e219 ), citric acid , tri - sodium citrate , purified water ( see section 2 , " jylimvo contains ethyl parahydroxy benzoate [ e218 ]) and sodium methyl pentahyd
this medicine contains the active substance glycopyrronium bromide , which belongs to a group of medicines called bronchodilators . this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten . this makes breathing difficult . using this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . if you use this medicine regularly , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from kidney problems . if you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). warnings and precautions talk to your doctor , pharmacist or nurse before using treatment with this medicine . stop using this medicine and contact your doctor immediately if you get tightness of the chest , coughing , wheezing or breathlessness . these may be signs of bronchospasm ( difficulties in breathing or swallowing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation each day at the same time of the day . this medicine should be used for 24 hours at a temperature not above 75 ºc . do not use more than your doctor tells you to use . your doctor will tell you how many capsules to use and how long you should continue using this medicine . how enurev breezhaler is used this medicine comes as an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : common ( may affect up to 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms are excessive thirst , hunger ( frequent urination ), rash , itching , hives , difficulty breathing , swallowing , dizziness . signs of allergic reaction may include swelling mainly of the tongue , lips , face or throat ( angioedema ). if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( 0 . 5 millilitres ) glycopyroniumbromide , equivalent to 50 milligrams ( 23 . 0 millilitre ) of glycopYRronium . - the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( 3 . 4 milliliter ) of Glycopyronium . the other ingredients in the inhalation powder are lactose monohydrate and magnesium stearate
riximyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". by sticking to the target of the target protein , riximyo slows down the rate at which the cell dies . this helps your immune system ( the body ' s natural defences ) to attack the cells . a ) non - hodgkin ' s lymphoma is a disease of the lymph tissue ( part of the immune system ) that affects a certain kind of white
do not use riximyo : - if you are allergic to rituximab , other proteins derived from the needles of yew trees , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have a severe active infection at the moment , or have a weak immune system - you suffer from severe heart failure or severe uncontrolled heart disease - you are suffering from granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ( see section
you will be given riximyo under the supervision of a doctor who is experienced in the use of this treatment . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may decide to change your dose . your doctor will decide on the most appropriate dose for you . the recommended dose is one infusion ( a drip called intra - venous infusion ) once a day . medicines given at the same time ( for example , with food , drink , or between meals ) are given to you by your doctor before each
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
what riximyo contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab when reconstituted as recommended . - the other ingredients are : 10 mg , 50 mg or 500 mg ( see section 2 for more information ). - the ingredients in the solvent are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide , hydrochloric acid ( see also section 2 " rixamyo contains sodium "), water for injections and solvent for infusion . see section 3 for further information . pack sizes : 1 or 2
the active substance topotecan actavis is a medicine that blocks the activity of a protein called epidermal growth factor receptor ( egfr ), which can be fatal if not treated with chemotherapy . it is used for the treatment of advanced cervical cancer that cannot be removed by surgery or radiotherapy . in this case topetecan actedavis treatment is combined with medicines containing cisplatin .
you must not be given topotecan actavis : if you are allergic ( or to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you are breast - feeding . your doctor will check your blood cell counts and tell you if they are too low . this will be done by your doctor or nurse while you are being treated with this medicine . you have ever had any kidney problems . if any of these apply to you , tell your doctor as soon as possible . do not breast - feed while you
the dose of topotecan actavis you will receive will depend on the disease being treated and on results of blood tests carried out before and during treatment . the usual dose for treatment of adults small cell lung cancer is 1 . 5 mg per square metre of body surface area once daily for 5 days . this treatment cycle will be repeated every three weeks . for cervical cancer , your doctor will increase your dose to a maximum of 0 . 75 mg every three days of the 5 - day treatment cycle . in addition , you will be given another anticancer medicines containing cisplatin . if you are not sure , talk to your
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects stop taking topotecan actavis and tell your doctor straight away if you notice any of the following serious effects : infections : very common ( may affect more than 1 in 10 people ): fever . your doctor will check your general condition and local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). your doctor may reduce the dose or stop the treatment temporarily or permanently , depending on your ability to fight infections . lung inflammation : rare ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 ± 2 and from a microbiological point of view , when stored in a refrigerator ( 2 to 8 ). the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %), glucose 5 mg / ml ( 0 . 5 %) solution for injection )
what topotecan actavis contains - the active substance is topotan . each vial contains 1 mg or 4 mg of topotecaan ( as hydrochloride ). after reconstitution with 1 ml of water for injection , 1 mg / ml solution contains 10 mg / 0 . 5 % of the solution . - the other ingredients ( excipients ) are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide ( see section 2 ). whattopotecaned actavis looks like and contents of the pack topoten actavis is a white to
the active substance in this medicine is rivastigmine hexal , which belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasterigmine works by blocking the enzymes that break down acetylCHoline , such as acetylchlorolinescerase and butyrylcholinesternase . by blocking these enzymes ,
you must not be given rivastigmine hexal - if you are allergic to dulutrombocytopenia or any of the other ingredients of this medicine ( listed in section 6 ). if you have had a previous skin reaction ( allergic contact dermatitis ). if this applies to you , tell your doctor . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . if you think any of these apply to you ( or you are in any doubt at all ), ask your doctor or pharmacist for advice before being given the product . you may be more at risk of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg per kilogram of body weight each day . you should continue taking this medicine until your doctor tells you otherwise . if you have not taken your medicine for more than three days , do not take the next dose until you have
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below have occurred with rivastigmine hexal : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common : may affect up to 1 in every 10 people anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares
keep this medicine out of the sight and reach of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . store below 30 . store in the original package in order to protect from moisture .
what rivastigmine hexal contains 64 the active substance in each hard capsule is rivastaigmine hydrogen tartrate . the other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ) and shellac . each rivanette hexal 1 . 5 mg film - coated hard capsule contains 1 . 25 mg hard capsule ( as gelatin ) and contains a white to off - white lyophilised powder ( e904 ). each r
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adult patients with kidney cancer ( renal cell carcinoma ) or liver cancer that has not responded to a specific anticancer medicine ( sorafenib ). how cabometyx works in people who have not been treated before , it blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . these proteins can be present in high amounts in cancer cells . your doctor will test for these changes . if you have any questions about how cab
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking cabomety if you : - have high blood pressure - have or have had an aneurysm ( enlargement or weakening of a blood vessel wall ) - have a tear in or around a blood valve wall - have diarrhoea - have recently had significant bleeding from surgery or within the last month - have had surgical procedures or dental surgery - have inflammatory bowel disease - have crohn
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . this medicine is for oral use . swallow the tablet whole with a glass of water . you can take cabometyx with or without food . try to take your daily dose at about the same time each day . do not stop your treatment unless your doctor tells you to . this will help you to get the best results and lower the risk of serious side effects . duration of treatment your doctor will tell you how long you should continue to keep taking cabomet
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines used to treat your side effects : tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea , feeling sick ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood , swelling , pain in
what cabometyx contains - the active substances are cabozantinib ( s ) and malate . each tablet contains either 20 mg cabozatinib or malate ( 23 mg / 5 . 5 mg ). each tablet is provided with a desiccant to reduce the risk of infecting your child . - the other ingredients are sucrose , apple puree , and water for injections ( see section 2 " cabostyx contains lactose "), lactose anhydrous , hydroxypropyl cellulose ( e463 ), croscarmellose sodium ( e468 ), colloidal silicon dioxide anhyd
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . your doctor will decide on the most appropriate dose for you . in this case , your treatment will be combined with another medicine of the same type ( called " monotherapy ") for the initial treatment . if you have lung cancer that has not responded to treatment
do not use pemetrexed hospira : - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before breast - feeding , during or after treatment , if you : - have recently received or are about to receive a vaccine against yellow fever . your doctor may decide to temporarily or permanently stop treatment with this medicine . - have or have previously had problems with your kidneys . before you are given this medicine , your doctor will check your blood and liver function to make sure that you have
the dose of pemetrexed hospira that you receive is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of the body . your doctor will use this body surface area for treatment as determined by your doctor based on your blood cell counts and on your general condition . if necessary , your doctor may also change the dose and frequency of administration . when prepared as directed , chemical and physical in - use stability has been demonstrated for approximately 9 hours at a concentration of 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : fever or infection ( common ): if you have a temperature of 38ºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you experience pain , redness , swelling or sores in your mouth ( very rare ). allergic reaction : if you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of infusion solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature ( 2ºc - 8ºc ). from a microbiological point of view , the product is a clear and colourless solution . if not used immediately , in
what pemetrexed hospira contains the active substance is pemetreepentahydrate . one vial ( 100 mg ) contains 100 milligrams of pemphrexed ( as besilate dihydrate ). two vials ( 500 mg ) contain 500 milligram of pemetereeped (as besilode dihydrine ). three vials [ 500 mg ] contain 1 , 000 milliggrams of pererexed . after reconstitution , the solution contains 25 mg / ml of solution . further dilution by a healthcare provider is required prior to administration . the
ganfort contains two active substances called bimatoprost and timolol , which work together to reduce pressure in the eye . both of these active substances are used to treat glaucoma . ganfort belongs to a group of medicines called prostamides . it works by interfering with a prostaglandin analogue ( analogue ) that is present at the back of the eye and helps to lower the amount of pressure in your eye . it is used in adults , adolescents , children and infants aged one month and above who have already received medicines called beta - blockers . the eye is a clear , watery
do not use ganfort eye drops : if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) if you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( signs include wheeziness , difficulty in breathing , and long - standing cough ) warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you suffer from coronary heart disease ( symptoms include chest pain , tightness , breathlessness , choking ), heart failure or low blood pressure 44 if you
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in the affected eye once a day . treatment should be started as soon as possible . keep the bottle tightly closed in order to protect from moisture . do not put the bottle near your neck . 5 . gently squeeze the bottle . 1 . wash your hands . tilt your head back . 2 . pull down your eyelid until there is a small pocket . 3 . put your eye back in place . continue treatment as usual . 4 . close the lid of your eye .
like all medicines , ganfort can cause side effects , although not everybody gets them . stop using the drops and see a doctor straight away if you notice any of the following serious side effects after taking a single dose ( multi - dose or single - dose ). very common side effects ( may affect more than 1 in 10 people ): - the eye redness . uncommon side effects these may affect up to 1 in 9 people : - sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of the eye ( inflammation ), difficulty in seeing clearly , redness ,
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture and eye infections . use within 4 weeks after first opening , and do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / 0 . 5 ml ) timolol ( 5 mg / ml ). - the other ingredients ( excipients ) are porphyridol maleate , 6 . 8 mg , benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what gansfort looks like and contents of the pack the clear , colourless to slightly yellow solution for injection in
gefitinib mylan contains the active substance gefitinib . it works by blocking the activity of a protein called epidermal growth factor receptor ( egfr ). this protein is involved in the growth and spread of cancer cells and is present in large amounts in patients with advanced stage of non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan : - if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have or have had any other lung problems . some lung problems can be serious and need immediate medical attention . your doctor may decide to reduce your dose , or stop treatment , if you have any of these conditions . - have ever had problems with your liver . if this applies to you , tell your doctor . children and adolescents do not give g
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you should take antacids on an empty stomach at least 2 hours before or 1 hour after taking gefitinib mylan . if you have trouble swallowing the tablet whole , talk to your doctor . do not take any other liquids until your doctor tells you otherwise . the tablet can be taken with or without food . take the tablet at about the same time each day . it is best to take at least one tablet at the same
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease ' ( i . e . uncommon , may affect up to 1 in 100 people ). gefitinib may cause severe skin reactions
what gefitinib mylan contains - each film - coated tablet contains 250 mg of gefinib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ) ( type k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol ( e1203 ), macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide e172 ( see section 2 under ' important information about some of the ingredients of g
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which certain types of red blood cells become abnormal . signs and symptoms include a low red blood cell count ( anaemia ) which cannot be controlled and can be caused by the lack of a sufficient number of redblood cell transfusions ( see section " how to treat mds "). in adult patients who cannot be transfused and who do not respond well enough to the treatment of their condition , red blood
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to have a pregnancy , ask your doctor for advice before taking this medicine . if you have thalassaemia ( a condition where the spleen removed ) or have had a blood clot , your doctor may recommend hormone replacement therapy ( see section " warnings and precautions "). if you had a previous blood clot . your doctor will discuss this with you and will recommend preventive measures ( including medicines used to prevent or prevent a
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before and during your treatment with reblozyl . you will be given the injection under the skin . the dose will depend on how much you weigh . the injections will usually be given in increments of 1 . 0 mg / kg of body weight . this dose will be adjusted by your doctor depending on your blood pressure . use in children and adolescents the recommended dose for children with myelodysplastic syndromes the maximum single dose is 1 . 75 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have any of the following serious side effects : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or in other parts of the body , blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions including rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for a single period of up to 24 hours at 2 8 . from a microbiological point of view , the product should be used immediately . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspaterscept . after reconstitution with eachml of solution , each ml contains either 50 mg or 100 mg ( 25 mg / ml ) of dulphurmagnesium ( e322 ). - the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( e524 ( e1521 ) to adjust ph adjustment . what rebl ozyl looks like
fotivda contains the active substance tivozanib . it is a protein kinase inhibitor that works by inhibiting the activity of a protein called alpha or interleukin - 2 , which is involved in the growth and spread of cancer cells . it works by stopping the growth of new blood vessels in patients with advanced kidney cancer who have not previously tried other treatments . it can be used either alone or in combination with another protein called beta - 2 ( alpha - 2 ) that has been shown to slow down or stop the progression of your disease .
do not take fotivda if : you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). you are breast - feeding . you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : if you have high blood pressure . your doctor will check your blood pressure before you start taking a medicine . if you think any of these apply to you , tell your doctor or pharmacist . while you are
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of fotivda is 1340 mg twice a day ( 21 mg capsules and 7 mg capsules ) for 7 days followed by 1 dose in the morning and 4 capsules in the evening . your doctor will tell you how many capsules to take each day . if you have the impression that the effect is too strong or too weak , talk to your doctor , pharmacist or nurse . the maximum recommended dose is 4 capsules a day . do not take more than the recommended
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). tell your doctor immediately if you experience any of the following symptoms : severe headaches , blurred vision , shortness of breath , changes in your mental state ( e . g . feeling anxious , confused or disorientated ). your doctor may want to monitor your blood pressure more closely while you are taking fotivda . you may need to reduce the dose you take , or stop taking this medicine for a short time . if your high
what fotivda contains - the active substance is tivozanib . each hard capsule contains 890 mg of tibs . - the other ingredients are : capsule contents : gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( e1520 ) and strong ammonia solution ( titanium dioxide , e171 ). capsule shell : tartrazine aluminium lake ( e129 ). printing ink : shellac ( 6000 iu ) and pre - filled vial ( 0 . 5 milligrams ) of powder for solution for injection , prop
stribild contains two active substances : elvitegravir ( an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of the activity of the immune system ( the body ' s natural defence system ). both of these active substances are used to treat hiv in adults and children aged 12 years and older who weigh at least 35 kg . they are also used in combination with other hiv medicines for the treatment of human immunodeficiency virus ( hiv ) infection . stribild works by reducing the amount of hiv
do not take stribild - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . during treatment , your doctor may tell you to stop taking any medicine containing tenofoviir disopyroxil . this will depend on your kidney function and whether you are taking any of these medicines : alfuzosin ( used to treat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age 35 the recommended dose is one tablet once a day by mouth . swallow the tablet whole with a glass of water . you can take your tablet with or without food . your doctor may change the dose of your medicine depending on how you respond to the treatment . if you take medicines called oral supplements ( such as antacids or laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ), take the tablet at least 4 hours
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the disease itself or by the medicines being used to treat it . serious side effects tell your doctor immediately : lactic acidosis ( excess l
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg of elvitesgravira ( 150 mg in mg , both of them are taken as tablets ), respectively , when they are taken together as tablets . - the other ingredients are : tablet core : amitriptyline , croscarmellose sodium , hydroxypropyl cellulose , lactose monohydrate , magnesium stearate , microcrystalline cellulose
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement , euphoria , and an inability to resist the impulse , drive or temptation to carry out certain activities that could harm yourself or others . you have been shown to experience rec
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . if you have been previously diagnosed with eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of these medicines . you may need to have a special diet while you are being treated or while being treated with z
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the usual dose of zyprexa tablets is one 5 mg tablet twice a day . your doctor may increase your dose to one 20 mg tablet once a day depending on your symptoms and on how well your medicine is working for you . how to take take the tablet at the same time each day . swallow the tablet whole with a glass of water . you can take your tablet with or without food . do not crush , chew or break the tablet . you may take your tablets with
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue . this may be a sign of blood clots in the veins . this side effect has been reported uncommonly ( may affect upto 1 in 100 people ) in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . zyprexa will be stored by the health professionals at the hospital or clinic . these measures will help to protect the environment .
zyprexa contains the active substance olanzapine . each zyprexa tablet contains 2 . 5 mg / 5 mg , 7 . 5mg / 10 mg , 15 mg / 20 mg . the other ingredients are : tablet core : lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate . tablet coating : hypromellose ( e464 ), titanium dioxide ( e171 ), carnauba wax . see section 2 under " important information about some of the ingredients of the tablet core " for further information . the different zy
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein . it is used to prevent bone loss in adult patients with osteoporosis when treatment is contraindicated or inadequate . prolia helps to make bone stronger by making it easier for bone to break . it reduces the amount of oestrogen that is made in the bones after the menopause . as a result of this , your body is unable to break down the excess of the female hormone . as an effect of prolia , bone becomes thin and fragile . what osteop
do not use prolia : if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using prolia if : you have a skin infection with symptoms such as a swollen , red area of skin on one side of your leg that feels hot and tender ( cellulitis ) you have symptoms of fever . these symptoms may be due to an allergy to latex . the needle in the pre - filled syringe contains a derivative of latex
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . one pre - filled syringe contains 60 ml of solution for injection , which should be given within 6 hours . it can be given as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . if you use more prolia than you should if you think you may have injected too much prolia , talk to your doctor , pharmacist or nurse . you may also be asked to wear stickers to remind you to take calcium and vitamin d
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor straight away if you notice any of the following skin infections ( cellulitis ). these symptoms may be due to prolia : swollen , red area of skin , usually in the leg , which feels hot and tender . these may be symptoms of fever ( see section " warnings and precautions "). prolia may cause pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw , discharge , numbness or a feeling of heaviness , or loosening of a tooth .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of your pre - filled syringe after exp . store in a refrigerator ( 2 - 8 ). do not freeze . you may remove prolia from the refrigerator and keep it at room temperature ( not above 25 ) for a single period of up to six months . after the injection , it may be stored either below 25 or up to 30 days at a temperature not above 30 , but do not throw away any medicines via wastewater or household waste . ask your pharm
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab ( 60 mg / ml ). - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard . not all pack sizes may be marketed .
aimirix is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection with the hepatitis a virus causes the liver to become swollen and inflamed . the virus can infect any part of the body , including faeces , serum or saliva . symptoms occur 3 to 6 weeks after infection . you may feel sick , have a fever , aches and pains , feel very tired , dark urine , palefaeces or yellowish skin or eyes ( jaundice ). the severity and type of symptoms vary from person to person . all symptoms can occur
you must not be given ambirix - if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . tell your doctor straight away if you get any of these signs . you should not receive any vaccine for hepatitis a or hepatitis b diseases . if you have a severe infection with a high temperature , the vaccine should be given at the same time as a minor infection such as a cold . warnings and precautions talk to your doctor , pharmacist or nurse before
always use ambirix exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one injection into a muscle ( usually in the upper arm ). your doctor will decide on the most appropriate dose for you , depending on how you respond to the injection . the injection will usually be given into the thigh muscle . you will receive a total of two injections . the injections should be given within 12 months . if you respond well to the first injection , the second injection may be given between 6 and 12 months after the first one . your doctor may decide to give extra doses
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness where the
what ambirix contains 26 the active substance is hepatitis a virus . each 1 ml pre - filled syringe contains 720 micrograms of elisa units ( equivalent to hepatitis b surface antigen ). the other ingredients are : 20 % human diploid ( mrc ), cells , aluminium hydroxide ( hydrated 0 . 05 %), saccharomyces cerevisiae ( e132 ), aluminium phosphate ( 0 . 4 %), sodium chloride and water for injections . the contents of the pack suspension is a white , slightly milky liquid , supplied in a glass vial . each carton contains 1 or 10 pre -
besero is a meningococcal group b vaccine . bexsero is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria cause infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by causing the body to produce its own protection ( antibodies ) against the disease .
do not use bexsero : - if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are vaccinated if : - you have a severe infection with a high temperature ( over 38 ). vaccination should be postponed until you have recovered from a minor infection such as a cold . your doctor may decide to delay vaccination if you have haemophilia or any other problem that may prevent your blood from clotting properly , e . g . blood thinners ( anticoagulants ) or treatment
always use bexsero exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 ml injection into the muscle of the thigh or upper arm . injections will be given every 2 to 5 weeks . you will receive three injections of the vaccine followed by an additional injection ( booster ). the first injection should be given at least 2 months apart . the interval between injections should not exceed 1 month . if you miss an injection , make another one as soon as possible . if it is more than 2 months since your last injection , your doctor will delay the interval
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the area of injection site hardness at the place of injection injection site the following side effects have been reported with this vaccine : common : 10 or more common : fever , loss of appetite , tenderness on the injectionsite , severe injection site tender
what bexsero contains - the active substances are recombinant neisseria meningitidis group b nhba fusion protein ( 1 , 2 , 3 , 50 micrograms ) and recombinant neuraminidase ( bnhba ). - the other ingredients are group b nasopharyngitis group b fungal protein ( 2 , 4 , 5 , 6 , 10 , 15 , 20 , 25 , 30 , 40 ) and outer membrane vesicles ( e . coli ). - omv - derived ( non - human ) group b fhbp fusion protein which is produced by recombinant d
what nitisinone mdk is this medicine is used to treat a rare disease called hereditary tyrosinemia ( hdk ) in adults , adolescents and children aged 1 year and above . due to this disease your body cannot break down the amino acid tyrosine ( amino acids are substances that are naturally present in the body ) and they accumulate mainly in the food and drink that you eat . by breaking down these amino acids you can help to eliminate them from your body and reduce the harmful substances that may be present in these substances . this medicine helps to reduce the amount of tyrosrine in your body . it
do not take nitisinone mdk - if you are allergic to any of the active substances ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . pregnancy , breast - feeding and fertility there is no data available on the effects on the ability to use a child ' s eyes . however , you should tell your doctor immediately if you have an eye examination . there have been reports of eye problems due to inadequate dietary control ( see section 4 for more information ). your doctor will monitor the effectiveness of the treatment and will take blood samples during the treatment to check for side
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended starting dose is 1 mg for every kg of body weight . this dose may be increased to a maximum of 20 mg for this patient population . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally take too many capsules , contact your doctor immediately . if possible
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 8 ). do not freeze . after first opening , nitisinone mdk may be stored at room temperature ( up to 25 ) for a single period of up to six months . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than six months at 2 to 25 unless dilution has taken place in controlled and validated ase
what nitisinone mdk contains - the active substance is nisinone . each hard capsule contains either 2 mg or 2 mg ( as monoclonal antibodies ). - the other ingredient ( s ) in the hard capsules are nitisine . each capsule is approximately 5 mm long and contains 5 mg or 10 mg of nitishinone . - the printing ink is gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ) and shellac glaze ( e1520 ) to help preserve the colour of the capsules and to help protect them from light . what you will find in the pack
docetaxel accord will be given to you by a doctor or nurse under the supervision of a doctor who is experienced in the use of anti - cancer medicines called taxoids . your doctor will decide on the most appropriate dose for you . the most frequently prescribed dose of docetaxell accord is breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer . for the treatment of advanced breast cancer the usual dosing options are docetxorubicin , trastuzumab or capecitabine . for early breast cancer with
do not use docetaxel accord : - if you are allergic ( hypersensitive ) to any of the active substances ( listed in section 6 ) - if your number of white blood cells is too low − if you have a severe liver disease . warnings and precautions before you are given this medicine , you will have blood tests to check that you have enough blood cells and that your liver is working properly ( see section 4 ). during the first few days after you are treated , you may experience some of the following : - very common ( may affect more than 1 in 10 people ): - very rare ( might affect up to 1
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m² ) and will determine the dose you should receive . method and route of administration docetaxell accord is given as an infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . based on the results of your blood tests , your doctor may change the dose and frequency of dosing depending on your
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel with other chemotherapeutic agents may be increased during the infusion . allergic reactions may occur very commonly ( may affect more than 1 in 10 people ). fl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store below 25 . store in the original package in order to protect from light . after dilution , the medicine should be transferred from the infusion bag and used within 6 hours ( up to 25 hours ). for infusion , the infusion solution should be used immediately . non - pvc bags may be stored for 48 hours at 2 to 8 . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the
what docetaxel accord concentrate and solvent for solution for infusion each ml of concentrate contains 20 mg film - coated tablet ( see section 2 ). the other ingredients ( excipients ) in the concentrate are as follows : 1 ml solvent ( for reconstituted pharmaceuticals ) solution for injection ( for diluted pharmaceuticals ). each 20 mg / ml vial ( for paediatric use ) contains 30 mg ( 3 . 5 mg / vial ). each 4 mg / 0 . 5 ml concentrate contains 80 mg ( 2 . 0 % w / v ). each 160 mg / l vial contains 300 mg ( 4 . 0
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that work by stimulating the brain to produce dopamine ( a chemical involved in learning and memory ). this medicine is used to treat impulsive , hyperactive adults who are not able to resist the impulse , drive or temptation to carry out certain activities that are deemed detrimental to the well - being , or to others . your doctor has prescribed this medicine for you to treat ' attention deficit hyperactivity disorder ' ( adhd ) in combination with current stimulant medication . current medication is not controlling adhd symptoms . the medicine is intended to be
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have low or high blood pressure , heart problems , or heart problems . tell your doctor if you fainted recently or have ever had thoughts or feelings of suicide or any other psychiatric conditions ( withdrawal symptoms ). increased heart rate , especially when you are elderly , has been reported in patients with high bloodpressure . if any of these apply to you , your doctor may tell you to stop taking this
your treatment should be initiated under the supervision of a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will determine the dose that is right for you . the dose will depend on your condition and your response to your treatment . the usual starting dose is 1 tablet per day . depending on how you respond to treatment , your doctor may increase your dose to 0 . 05 mg / 0 . 12 mg twice a day depending on your bodyweight . your
like all medicines , this medicine can cause side effects , although not everybody gets them . you may feel unwell when taking your medicine . serious side effects tell your doctor straight away if you notice any of the following side effects : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure with symptoms such as headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if any of these side effects occur , stop taking intuniv and talk to your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister pack after exp . this medicine does not require any special temperature storage conditions . keep the tablets in the original blister pack in order to protect from moisture .
what intuniv contains - the active substance is guanfacine hydrochloride . 1 mg prolonged - release tablets : each prolonged release tablet contains either : 1 mg guanFacine ( see section 2 under ' important information about some of the ingredients of this medicine ') or 2 mg guinfacine ( seen section 3 under ' some of these ingredients ') each prolonged -release tablet contains : 3 mg guaconfacine acid - ethyl acrylate copolymer - the other ingredients are : − tablet core : lactose monohydrate , povidone type a , microcrystalline cellul
ecalta contains the active substance anidulafungin and is used to treat adults and children from 1 to 18 years old with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida . ecalta belongs to a group of medicines called echinocandins . these medicines prevent serious fungal infections from getting worse by preventing them from growing . they also prevent fungal cell walls from breaking down and infecting other organs , such as the skin , organs , and the cells that are responsible for their growth . ec
do not use ecalta - if you are allergic to anidulafungin , other echinocandins , or caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ecaltra . your doctor will monitor your liver function . if you have liver problems , your doctor may decide to reduce your dose or stop your treatment with anaesthetics . in some cases , your treatment may need to be slowed down or stopped . tell your doctor or nurse immediately if you experience an allergic reaction
always use ecalta exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the treatment will be started by a doctor or nurse who is experienced in the use of this type of medicine . the recommended dose is 200 mg or 100 mg once a day . use in children and adolescents ( aged 1 to 18 years ) the recommended starting dose is 3 . 0 mg , followed by 200 mg , 1 . 5 mg and 100 mg two days later . the dose may be adjusted depending on the patient ' s weight and body surface area . your doctor will calculate the dose of ecalt
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : potentially life - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . stop taking ecalta and seek medical help immediately if you experience any of these serious or potentially life threatening effects : - convulsion ( seizure ), flushing , rash , pruritis , itching , hot flush , hives , sudden contraction of the muscles , wheezed , coughing or difficulty of breathing other side effects very common side effects ( may affect more than
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . the reconstituted solution should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc . the infusion solution may be stored at ambient room temperature ( up to 25 ) for up to 48 hours or at room temperature
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 micrograms ( 23 . 5 mg ). - the other ingredients of the powder are mannitol ( e421 ), polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid 30 % and water for injections ( see section 2 ). what Ecalta looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 ml of concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is produced by recombinant dna technology using pegylated human coagulation factor viii ( rdviii ). how adynovi works factor iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a ( the body ' s natural defence system ) it is not possible to increase the amount of factor v iii in the blood at the same time , so it is important to continue to work for as long as your doctor prescribes it for you and your child . ad
do not use adynovi if you are allergic to rurioctocog alfa pegol , octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using adynov : - if you have ever had an anaphylactic reaction ( a severe , sudden allergic reaction to any substance present in the blood ). this may be life - threatening . you should tell your doctor immediately if any of these apply to you . during treatment with ad
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide on the most appropriate dose for you . the dose you receive will depend on your condition and the type of bleeding that you are at risk of . the doctor will determine the dose that is appropriate for you and will prescribe the replacement therapy that is best suited to you . if you are not sure , talk to your doctor or pharmacist before you are given this medicine . the recommended dose is one tablet once a day to reduce the risk of bleeding . the usual dose of adyn
like all medicines , this medicine can cause side effects , although not everybody gets them . if sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , general feeling of being unwell , dizziness and loss of consciousness . if severe symptoms such as difficulties in breathing or fainting occur , prompt emergency treatment is immediately available . patients who have received previous treatment with factor viii ( more than 150 days
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a single period of up to 3 months . after this period , this medicine expires at the end of this 3 month period or it can be stored for a maximum of 3 months , whichever is earlier . if not used immediately , in
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu ( international units ). - the other ingredients are : pregelatinised water for injections , mannitol ( e421 ), trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride diydrate , tris ( hydroxymethyl ) aminomethane , polysorbate 80 , sterilised
rekovelle contains follitropin delta , a follicle stimulating hormone ( fsh ), which belongs to a group of hormones called gonadotropins . fsh is a natural hormone produced naturally in the body by the cells of the ovaries . it is used to stimulate female fertility in women undergoing assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ( intrp ). it works by stimulating the production of ovaries , which are responsible for producing many egg sacs .
do not use this medicine if any of the above apply to you . if you are not sure , talk to your doctor , pharmacist or nurse before using rekovelle . warnings and precautions you should tell your doctor if : you have a problem with your fertility problems . you are allergic to follicle stimulating hormone ( fsh ). you have enlarged ovaries , cysts on your ovaries ( polycystic ovarian disease ), bleeding from the vagina ( an early menopause ), malformations of the sexual organs ( see section " pregnancy , breast - feeding and fertility "). you have fibroids of the uterus
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you at the start of your first treatment cycle . your doctor will prescribe a low dose of anti - müllerian hormone to stimulate your ovaries to produce stimulation with gonadotropins . the dose is based on your blood weight . you will have a blood sample taken during the last 12 months to check how well the medicine is working for you . the duration of treatment depends on your body weight and how you respond to treatment . how much re
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones ( infertility ) this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain , discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea may be more common in women than in men , but it is not known whether it is caused by rekovel
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . rekovelle may be stored at room temperature ( up to 25 ) for a single period of up to 3 months , but not beyond 3 months . after this period , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 months at 28
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 milligrams of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 million international units ( iu ), which are equivalent to 1 . 5 micrograms ( 23 . 3 microgram ) of follnitropin delta in each millilitere of solution ). - the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation contains either of these active substances . in adults , the recommended dose is one inhalation twice a day ( morning and evening ). in children and adolescents ( 12 years of age and older ) and adolescents weighing at least 92 kg , the usual dose is two inhalations ( 0 . 5 ml ) once a day . this is equivalent to a daily dose ( 92 / 22 mg ). for patients with chronic obstructive pulmonary disease ( copd ), asthma is the most common form of asthma . in adolescents (
do not use revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ellipta . ellipta has not been studied in patients with liver disease . it is not known whether ellipta causes side effects . if you have moderate or severe liver disease , your doctor may lower the dose of the lower strength of ellipta to 92 / 22 . tell your doctor if you suffer from heart problems , high blood pressure , tuberculosis ( t
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use asthma the recommended dose for asthma is one inhalation twice a day ( morning and evening ) with fluticasone furoate and 22 mg vilanterol . if you have severe asthma , your doctor may prescribe the higher strength inhalation ( two inhalations once a day ), with either one of the following strengths : fluticastonefuroate 22 mg / m2 of body weight and one of either the other strengths ( one and a half inhalations of v
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while using ellipta , stop using this medicine and contact your doctor immediately : skin rash , hives , redness swelling , sometimes of the face or mouth ( angioedema ), feeling very wheezy or coughing , having difficulty in breathing , feeling weak or light headed ( which could lead to collapse or loss of consciousness ) immediate breathing difficulties if you have immediate breathing problems while using revint
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 microlitres ( 6 . 0 mg / ml ). - the delivered dose is as follows : - the dose depends on the quantity to be inhaled each day . - the recommended dose for adults , adolescents and children ( 12 years of age and older ) weighing 92 kilograms or more : - each 92 micrometre inhalation delivers a deliverance of 184 micrometres ( 7 . 0
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , which is also known as a nucleosidermal necrolysis ( nrti ) and tenofovir , which are all known to be active substances . each active substance works in exactly the same way as the other active substances , making it easier for the virus to multiply . these active substances are used in combination with antiretroviral
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects , such as dizziness and drowsiness , have been reported . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much to take try to take the tablet at the same time each day . you can take it with or without food . at
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor immediately
what atripla contains ∑ the active substances are efavirenz , emtricitabine and tenofovir disoproxil . ∑ eachatripla film - coated tablet contains 600 mg of eflavirenz ( as antiretroviral therapy ), 200 mg ( as emtravir antitabine ), 245 mg [ as tenfumarate ] ∑ tablet core : croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atri
orgalutran contains the active substance ganirelix . it belongs to a group of medicines known as anti - gonadotrophin ( gnrh ). it is a copy of the natural gonadonrophin releasing hormone ( ngrh ) that gnrh regulates . stimulation of the ovaries leads to the release of gonadsotrophins ( a type of follicle stimulating hormone ) into the cells of the body ( the follicles are small round sacs that contain the egg cells ). this enables the body to release the immature egg cells , which are then collected and given to you as follicles
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be hypersensitive ( hypersensitive ) to gonadotrophin releasing hormone ( gnrh ), a gnrh analogue . if you have a moderate or severe kidney or liver disease and are planning to become pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine , as you may develop an active allergic condition . additional monitoring and treatment may be necessary . allergic reactions allergic reactions are generalised ( hives
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran will only be given to you by a doctor who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ) on day 2 or day 3 of each treatment cycle . your doctor will decide on a suitable injection site for you . the recommended dose is one injection under the skin ( subcutaneously ) every 5 to 6 weeks . you will be given orgal
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( e . g . redness and swelling ). if the local reaction is severe , it usually disappears within 4 hours . uncommon ( may affect up to 1 in 100 people ) is headache , nausea , malaise . very rare ( frequency cannot be estimated from the available data ) is allergic reactions ( rash facial swelling with difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat with difficulty in breathing or swallowing ( ang
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . syringes are for single use only . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . once opened , clear , particle - free solutions should be used immediately .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol ( e421 ) and water for injections ( for the ph ) and sodium hydroxide ( e524 ) which are also used to adjust the amount of acic acid in the vial ( see section 2 " what you need to know before you are given this medicine " and " other information about some of the ingredients of the product " in section 2 ) - the solvent is a clear , colourless aqueous solution . the
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". where " b " is found on the surface of this cell , it attaches to the target and kills it . how blitzima works blitzima can be used in adults with : a ) non - hodgkin ' s lymphoma ( a disease of the lymph tissue ( part of the immune system ) in which a small number of a certain kind of white
do not use blitzima : if you are allergic to rituximab , other proteins that are derived from the needles of yew trees , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection with a weak immune system . if you suffer from severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor , pharmacist or nurse before using blitzima if : you have ever had granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ( see section " other medicines and blitz
your treatment with blitzima will be overseen by a doctor who is experienced in the use of this treatment . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may lower your dose . blitzima is given as a drip ( intravenous infusion ). medicines given before each blitzima administration you will be given blitzima in combination with other medicines ( pre - medication ) to reduce the risk of side effects . the duration of your treatment will depend on your condition . for non - hodgkin ' s lymphoma
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicinal product does not require any special storage conditions . after first opening , the product should be used immediately . however , if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2ºc to 8ºc unless dilution has taken place in controlled and validated aseptic conditions . keep the container in the outer carton in order
what blitzima contains - the active substance is rituximab . each ml of solution contains 10 to 100 mg of the active substances . - each vial of solution for infusion contains 10 mg , 50 mg or 500 mg of ritukimab in 10 ml . - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for injection or infusion . each pack contains 2 vials , 50 ml or 1 vial . not all pack sizes
roactemra contains the active substance toilizumab , a so - called monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the body ). it blocks the activity of a protein called interleukin - 6 , which is involved in causing the inflammation in your body . in patients with this condition , it is not possible to get relief from symptoms such as pain and swelling in your joints without the disease . your doctor may decide to give a lower dose ( 0 . 5 mg ) if you have moderate to severe active rheumatoid arthritis ( an autoimmune disease
do not use roactemra : if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . warnings and precautions talk to your doctor , nurse or pharmacist before using the infusion . if you think any of these apply to you , tell your doctor or nurse straight away . you may need urgent medical attention if you experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips , skin rash , or any other signs of infection . infections tell your
always use roactemra exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the intravenous infusion will be given to you by a doctor or nurse who is experienced in the treatment of intravenous use . how much to use adults the recommended dose is one 8 mg film - coated tablet once a day for 4 weeks . your doctor will decide how many weeks you need and how long you need to use . children and adolescents ( aged 4 years and above ) the recommended starting dose is two 8 mg tablets twice a day ( as a drip in the
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in patients taking the medicine ( see section 3 " warnings and precautions "): very common side effects ( may affect more than 1 in 10 people ): allergic reactions such as difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections such as fever and chills , mouth or skin blisters and stomach ache signs and symptoms of liver toxicity ( rare , may affect up to 1 in 1000 people ): tired
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions .
what roactemra contains - the active substance is tocilizumab . each ml of solution contains 4 mg of 80 mg of tociluzumab when reconstituted as recommended . each 20 ml vial contains 10 mg / ml of 200 mg ( as directed by your doctor ). - the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactoremra looks like and contents of the pack roactremra is supplied as a concentrate for solution for infusion . roact
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . onbrez bronz inhaler is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine relaxes these muscles , making it easier for air to get in and out of the lungs when you breathe in .
do not use onbrez breezhaler : if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma . warnings and precautions talk to your doctor , pharmacist or nurse before using onbrezer if you : have heart problems . have epilepsy . have thyroid gland problems ( thyrotoxicosis ). have diabetes . if any of these apply to you , tell your doctor or pharmacist immediately . if you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine . these could be signs of a
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the usual dose is one 150 microgram capsule twice a day . your doctor may increase your dose to 300 micrograms once a day depending on how you respond to the treatment . you should use your inhaler at least 24 hours after you last inhaled it . how to use onbrez breezhaler you will find an inhaler and capsules ( in blisters ) that contain the medicine ( inhalation powder ) that you need to inhale . use the onbre
what onbrez breezhaler looks like and contents of the pack the hard capsules are white to off - white , capsule - shaped , with " 150 " debossed on one side and " indacaterol maleate " on the other side . the capsule content is composed of lactose and the capsule is made of gelatin . the capsules are packed in blisters . the hard capsule is packed in gelatin . an inhaler comes in boxes of capsules with blisters and the capsules contain a white powder . your doctor or nurse will tell you what you need to take to get the best results . what onbre
clopidogrel hcs is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , anti platelet medicinalproducts reduce the chances of blood clots forming ( a process known as thrombolysis ). clopidogsrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), an event known as atherothrombosis ,
do not take clopidogrel hcs - if you are allergic to clopilogrel or any of the other ingredients of this medicine ( listed in section 6 ). - have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - have severe liver disease . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions the following applies to you ( or you are not sure ), or to any member of your family or carer : if you have been told by your doctor that you are at increased risk of bleeding ( such as -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you a lower dose ( such as 300 mg of one 75 - day treatment course of 75 days ), but you should not take more
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel hcs contains - each film - coated tablet contains 75 mg of clopridogrel ( as hydrochloride ). - the other ingredients ( excipients ) are listed in section 2 under ' important information about some of the ingredients ' ( see section 6 ). - clopide hcs also contains hydrogenated castor oil . - tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil in the tablet core ; polyvinyl alcohol , titanium dioxide ( e
febcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that have not responded to other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other antibiotics such as cephalosporins . if you have had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ) which has been associated with severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing . warnings and precautions talk to your doctor , pharmacist or nurse before you are given fetcro
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how fetcroja is given this medicine is given as an infusion ( a drip ) into a vein . it usually takes about 3 to 2 weeks . your doctor will decide how many treatments you need and how often you need to take it . how often and for how long your treatment will be given the doctor will check you for infection . it is very important that you tell your doctor if your infection is getting worse . if you get any pain during the fetcroja infusion , it is important that
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : - severe allergic reaction - sudden swelling of your lips , face , throat or tongue - a severe rash or other severe skin reactions - difficulty swallowing or breathing - signs of this reaction may include diarrhoea , stools , blood or mucus . treatment may be stopped or medicines given to slow bowel movement ( see section 2 ). other possible side effects talk to your doctor , pharmacist or nurse if you are worried about any
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of ccfiderocol . - the other ingredients ( excipients ) are sucrose , sodium chloride and sodium hydroxide ( see section 2 ). what fetcroJA looks like and contents of the pack fetcroja is a white to off - white powder for concentrate for solution for infusion supplied in a glass vial . each carton contains 10 vials .
depocyte is used to treat a condition called lymphomatous meningitis in adults , adolescents , children and infants from one month of age , who have not previously been treated with a similar type of lymphoma tumour cells . depocyte works by attaching itself to the protective membranes of the brain and spinal cord . by attaching to these protective membranes , depocyte is able to kill and slow down the rate at which lymphoma cancer cells multiply .
do not take depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a meningeal infection . warnings and precautions severe neurological side effects have been reported with depocyte . symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop taking depocyte and contact your doctor immediately . you should not take any dexamethasone tablets to treat unwanted effects . if your side effects do not improve or get worse , tell your doctor
always use depocyte exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . for the treatment of cancer in the lumber sac , depocyte is given as injections of 1 to 5 micrograms of dexamethasone in each 5 ml vial . each depocyte dose will be monitored by your doctor if you experience any side effects . your doctor will decide on the correct dose of depocyte based on your body surface area ( temperature 22 to 30 ). after withdrawing depocyte from the vial , proper precautions should be taken to avoid exposure to a cytotoxic drug .
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often during your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ) very common : may affect up to 1 in 10 people very rare ( affects less than 1 users in 10 , 000 ) reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . depocyte must be stored in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . once depocyte has been removed from the refrigerator , it should be used within 4 hours . if depocyte is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than one hour at 2 to 8 , unless you notice severe discolouration , a
what depocyte contains - the active substance is cytarabine . each millilitre of suspension contains 10 mg cytabine ( equivalent to 5 mg / ml ). each vial of 50 millilitres contains 50 milligrams . - the other ingredients ( excipients ) are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoylophosphatidoylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a clear , colourless solution for injection . it is supplied in
the active substance in bemrist breezhaler is indacaterol , which belongs to a group of medicines called bronchodilators . it works by relaxing the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . the effect of mometasone furoate on these muscles is similar to that of corticosteroids , which are used to treat adult patients who have a history of breathing problems and who have had them for a long time . attacks of asthma are caused by the swelling and irritation ( inflammation ) in the smaller airways
do not use bemrist breezhaler if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have heart problems , such as an irregular or fast heartbeat you have thyroid gland problems you have diabetes , high blood sugar , seizures or low level of potassium in your blood you have severe liver problems . you have tuberculosis ( tb ) of the lung or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules are for oral use . swallow the capsules whole with a glass of water . you can take the medicine with or without food . it is important that you continue to use the medicine until your doctor tells you otherwise . if your asthma does not go away or your symptoms do not improve after a few weeks , contact your doctor for advice . how much to use your doctor will tell you exactly how many capsules to use and how often to use . how to use bem
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( might affect up to 1 in 100 people ): swelling of either the tongue or lips ( face or throat ), angioedema ( see section " warnings and precautions "). other side effects other possible side effects are listed below : very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light and moisture . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each delivered dose ( the dose that leaves the mouthpiece of the inhaler ) ranges from 125 to 62 . 5 micrograms ( equivalent to 173 milligrams ) in each metered dose . - the other ingredients ( excipients ) in the capsules are : 150 microgram ( 3 . 0 microgram ) indacatersol ( 4 . 4 microgram ), 80 microgramm ( 5 . 1 microgram ). - the tablet ( s ) that
the active substance of zyllt , clopidogrel , belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ) which can lead to atherotrombotic events ( e . g . stroke , heart attack , or death ). your doctor has prescribed zylltic to help prevent the formation of
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before taking zllt . warnings and precautions it is important that you tell your doctor or pharmacist if you : have an increased risk of bleeding , such as - a medicalcondition that puts you at
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may lower your dose to 300 mg once a day . your doctor will tell you the dose to take . the usual dose for adults , adolescents and children is one
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). - the other ingredients are : tablet core : lactose ( see section 2 under ' zllt contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what
lamivudine teva contains the active substance lamivudrine . lamivuda teva is used for the treatment of long term ( chronic ) hepatitis b infection in adults , adolescents and children aged 12 years and older . lamibudineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver , and so is life - threatening . in patients with long term (" chronic " infection , it can cause liver damage . your doctor
you must not be given lamivudine teva : - if you are allergic , or are breast - feeding . warnings and precautions 28 talk to your doctor , pharmacist or nurse before you are given this medicine if any of the following apply to you ( or you are not sure ), or if your child is not sure , talk to a doctor or nurse straight away before being given the medicine : - you have liver disease such as hepatitis c . - you are overweight . your doctor may ask you to have blood tests periodically during treatment with your medication . see section 4 for more information . if you have not been given lam
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you keep taking it every day until your doctor tells you otherwise . you should continue to take it until your infection has gone away or until your illness has completely gone . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how long to continue to follow your doctor ' s advice about how long you should keep taking lamiv
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects of lamivudine teva are related to other conditions linked to hepatitis b . the following side effects have been reported during therapy for ' hepatitis b ' in clinical trials : very common side effects ( may affect more than 1 in 10 people ): tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea and increases in liver enzymes . these may be signs that the liver is not working properly and may tighten the muscles . allergic reaction ( rare , may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - each film - coated tablet contains 100 mg of lamivu . - the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ) and talc ( e553b ). printing ink : shellac , red ink ( e904 ), black ink ( shellac ), white ink ( phthalate ) and iron oxide red ( e
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not contain enough red blood cells . the symptoms can include fatigue , weakness and shortness of breath . it is usually caused by the lack of the natural hormone erythropoietin ( a substance produced by your kidneys ). your doctor has given you nespo to encourage your bone marrow to produce more redblood cells ( e . g . darbepoetin alfa ). chronic renal failure ( symptomatic anaemia ) in patients with chronic renalfail , kidney failure or kidney failure .
do not use nespo : if you have high blood pressure or are taking other medicines . if you think you may be allergic , ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given neespo ( darbepoetin alfa ) or r - huepo . patients who are not able to take medicines to treat sickle cell anaemia may experience epileptic fits ( seizures ), convulsions or fits . patients with liver disease who are taking drugs to treat anaemia have an allergy to latex . the needle in the pre
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before you are given nespo to check your haemoglobin level . the usual starting dose is 10 micrograms per kilogram of body weight once daily . if you are not sure about this , talk to your doctor or pharmacist . the dose may be increased or decreased depending on your condition . the doctor will tell you how many injections you need and how often you need to have . a haemogram level between 10 and 12 microgram s will be measured using the pre - filled syringe .
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) high blood pressure ( hypertension ) fluid retention ( oedema ) rare ( affects less than 1 to 100 users in 10 , 000 ) serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ), shortness of
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep your syringe in the original package in order to protect from light . after first opening of the vial , you may remove your vial from the refrigerator and allow it to reach room temperature ( up to 30 ) for a single period of up to 7 days , but not beyond this period . keep in touch with your doctor , pharmacist or nurse at all times .
what nespo contains - the active substance is darbepoetin alfa . each ml of a pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . - the other ingredients are sodium phosphate monobasic , sodium phosphate dibasic ( e1200 ), sodium chloride , polysorbate 80 ( e433 ) and water for injections . the solvent is a clear , colourless to slightly pearly liquid and cloudy . 1 ml solution is available in packs containing 4 pre -
macugen is a solution for injection into the eye called pegaptanib . this medicine works by stopping abnormal formation of new blood vessels in the eye . macugen is used for the treatment of adults with macular degeneration . people with this disease have vision loss caused by damage to a part of the retina called the macula ( the thin layer at the back of the eye ). macula is the layer that surrounds the eye ( amd ). as a result , abnormal blood vessels grow in the retina and become larger . this makes macula less able to pump blood through it . these new blood structures can bleed and leak fluid
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in or around the eye . warnings and precautions talk to your doctor , pharmacist or nurse before using macugen . an infection or bleeding in the eye may occur after macugen injection . tell your doctor immediately if you experience the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision . these may be the signs of a problem with your eye .
mugen will be given to you by a doctor or nurse who is experienced in the use of injections . always use macugen exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . macugen is given as a single injection into the back of the eye , usually every 6 to 9 weeks . the injection must not be injected into the vitreous part of your eye . your doctor will clean your eye with some local anaesthetic ( numbing medicine ) to reduce any pain you may have after the injection . if you think you may be allergic to antibiotic eye drops ,
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction or angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea ). the frequency of these side effects is not known ( frequency cannot be estimated from the available data ). an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms are described in section 2 under " warnings and precautions " and in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . the medicine should be used immediately after first opening .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains : - a pre -
palifermin belongs to a group of medicines called escherichia coli . palifermin works by blocking the growth of epithelial cells in the mouth and digestive tract , which are tissues that line the skin . by blocking these growths the active substance is able to enter the bloodstream and relieve mucositis , causing soreness , dryness and inflammation of the mouth . this side effect is most common in patients receiving treatments to treat your blood cancer . if you have or have had problems with your bloodcancer before , you may receive chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation
do not take kepivance - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children or adolescents under 18 years of age . other medicines and kepacivance tell your doctor or pharmacist if your child is taking , has recently taken or might take any other medicines . this includes any medicines obtained without a prescription , such as heparin . pregnancy and breast - feeding kep
how kepivance is given your doctor will decide on the dose of cancer treatment that you will receive . the recommended dose is one 60 mg film - coated tablet . your doctor may decide to increase your dose to a maximum of one kilogram . it will be given as an intravenous injection into a vein ( intravenously ). if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , raised levels of lipase and amylase levels in the blood , and decrease in the amount of digestive enzymes produced in the
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid ( see section 2 ). what kepvelance looks like and contents of the pack kepalivance is a white powder supplied in a glass vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cicagrelcet , which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , just below the thyroid gland , that produce hormones that help the body to break down fat ( hypercalcaemia ). in patients with secondary hyperparathyroidism , patients with serious kidney disease who are not on dialysis may be more likely to have problems with their kidneys . treatment with waste products can reduce the amount of calcium in the
you must not be given cinacalcet accordpharma : - if you are allergic ( or to any of the other ingredients of this medicine ) or if you have low levels of calcium in your blood . your doctor will monitor your blood calcium levels regularly while you are being treated with this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : - have ever had or might now have seizures ( fits or convulsions ). - have a history of seizures . - have liver problems . - suffer from heart failure . if any of these apply to you ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma should be taken orally with or without food . the tablets should be swallowed whole with some water . your doctor will take regular blood samples during treatment to determine the correct dose for you . for secondary hyperparathyroidism , the recommended starting dose for adults , adolescents and children of 3 years of age and older and weighing at least 18 kg is 0 . 20 mg per kg body weight . if you take more c
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches , cramps or seizures , as these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat , which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice straight away ( see section 2 ). common (
what cinacalcet accordpharma contains - the active substance is cinagrelcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinacecalcet ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ) and iron oxide yellow ( e172 ). see the end of this leaflet for further information about some of the ingredients . what c
jentadueto contains two different active substances called linagliptin and metformin . both of these active substances help to control blood sugar levels in adult patients with diabetes called ' type 2 diabetes mellitus '. this medicine works by blocking the action of two different proteins called dipeptidyl peptidase - 4 inhibitors ( dps - 4 ) that are involved in the production of sugar in the body , called biguanides . this helps to keep blood sugarlevels normal and helps to prevent diabetes from getting worse . it is used for the treatment of a condition called sulphonylureas or emp
do not take jentadueto if : you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). you have severely reduced kidney function . you have uncontrolled diabetes with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see section 4 ). this condition can also be life - threatening and requires immediate medical attention . if any of these apply to you , tell your doctor , pharmacist or nurse . warnings and precautions talk to your doctor before taking j
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should only be prescribed to you by a doctor who is experienced in the treatment of patients who are currently taking metformin . your doctor will prescribe individual tablets of linagliptin to help you stay on the diet and exercise recommended by your doctor . it is important that you continue taking this medicine until your doctor tells you otherwise . if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor , pharmacist or nurse . if
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms of low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion ( hypocaemia is a very rare , may affect up to 1 in 10 , 000 people ), but very serious side effect called lactic acidosis ( see section " warnings and precautions "). stop taking the combination jent
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after exp . store in the original package in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . if you notice any visible signs of tampering , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
the active substances are linagliptin and metformin hydrochloride . each jentadueto 2 . 5 mg / 850 mg film - coated tablet ( tablet ) contains two different excipients , one for each kilogram of body weight , and the other for each million iu / 1 , 000 iu ( tablet ). the other ingredients are : in the tablet core : aspartate aminotransferase ( e1201 ), talc , propylene glycol ( e1520 ). in the film - coating : indigo carmine ( e132 ), maize starch , silica ,
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older . it belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it works by preventing hiv from multiplying and infecting other people who are infected by hiv . it is used in combination with other hiv treatments . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : - you are taking or have recently taken any other medicines , including : - carbamazepine , oxcarbazepine or phenobarbital or phenytoin - medicines used to treat epilepsy ( seizures ) - rifampicin or rifapentine - medicines to treat some bacterial infections ( such as tuberculosis ) - omep
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take adults ( 18 years of age and older ) the recommended dose of edurant is 1 tablet of rifabutin ( a medicine used to treat some bacterial infections ) once a day . your doctor will tell you how long you should continue to take it . if you have the impression that the effect is too strong or too weak , talk to your doctor , pharmacist or nurse . the dose may need to be adjusted by your doctor . if your doctor thinks that edur
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream ( triglycerides , lipase , bilirub
what edurant contains - the active substance is rilpivirine . each film - coated tablet contains rilpaline hydrochloride . each pctfe / mpfe / pfe / ppfe / m2 tablet contains 25 mg of rilpelirine ( as monohydrate ). - the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . tablet coating : cellulose ( e460i ). tablet coat : lact
avandamet tablets contain two different medicines called rosiglitazone and metformin . these two medicines help to control the level of sugar in your blood when you have type 2 diabetes . people with type2 diabetes either don ' t make enough insulin or their body does not make enough of a insulin to control their blood sugar levels . the insulin that your body makes does not work as well as it should , and so the body has to either either make too much of a sugar or not enough of it . how and where to take avandamanet is a sulphonylurea . it is used
follow all your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor , pharmacist or nurse if you are not sure . do not take avandamet if any of the following apply to you : you are allergic ( hypersensitive ) to rosiglitazone or metformin . you are breast - feeding . warnings and precautions talk to your doctor or pharmacist before taking avandamanet if : you have been in close contact with someone who has had a heart attack or severe angina . you have ever had heart failure or have had
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is achieved gradually over 1 to 8 weeks . the maximum dose is reached gradually over 4 weeks . your doctor will decide the right dose for you . the dose may be increased or decreased depending on your condition . how long to take your daily dose depends on how well your body responds to the medicine . if you have the impression that the effect of ro
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions are rare . tell your doctor straight away if you notice any of the following : raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . these symptoms are usually mild to moderate and go away within a few days . stop taking the medicine and contact your doctor immediately . lactic acidosis has been reported in patients taking metformin . if you have severe kidney disease , symptoms of lacticacidosis include rapid breathing , cold stomach
keep this medicine out of the sight and reach of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp .
what avandamet contains - the active substances are rosiglitazone and metformin . each tablet contains either one or two of the following excipients : one tablet ( tablet of 1 mg ) rosIGlitazon ( 500 mg ) metforma , the other being two tablets ( tablets of 2 mg ). each adult film - coated tablet ( s ) is made up of two different strengths , both of which are used for the treatment of patients with chronic obstructive pulmonary disease ( cdph ). the other ingredients are tablet core : hypromellose , microcrystalline cellulose
clopidogrel mylan is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , anti platelet medicinalproducts reduce the chances of blood clots forming ( a process known as thrombolybosis ). clopidoggingrel melan is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), an event known as atherothrombosis
do not take clopidogrel mylan 31 - if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). - have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - have severe liver disease . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking clopridogrelmylan : if you have an increased risk of bleeding including - a medicalcondition that puts you at risk of internal bleeding ( such
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose of 300 milligrams ( one 75 - mg tablet ), once at the start of treatment , to a maximum of
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel mylan contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 for further information on the ingredients ). tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide [ e172 ], talc and mac
doptelet belongs to a group of medicines known as thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease ( low platelet count ) in adults , adolescents and children ( 12 years of age and older ) with a condition called thromboocytopenia . it is used in a medical procedure to reduce the risk of bleeding . it works by reducing the number of platelets in the blood . platelets are blood cells that help the blood to clot and stop bleeding .
do not take doptelet - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have or have had blood clots in the veins or arteries , as this may increase the risk of blood clotting ( see section 4 ). - you are being treated for cancer . - you take the contraceptive birth control pill or hormone replacement therapy . - have recently had surgery or are seriously injured . - 23 you are overweight or have advanced chronic liver disease . children
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day . however , your doctor may increase your dose to 8 mg one day . if you take more doptelet than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . you may need to take the tablets with or without food . your doctor will tell you how many tablets to take and how often you should take them . if possible , you may take one 20 mg tablet twice
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( likely to affect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains an active substance called avATrombapag maleate . each tablet contains 20 mg of avatriopag ( as besilate ). - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ), microcrystalline cellulose , crospovidone type b [ e132 ], silica , colloidal anhydrous , magnesium stearate . tablet coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these are used to monitor the heart arteries ( heart rate ) and the muscles in the heart . rapiscan is used in adults to perform a type of heart scan called ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken onto the muscles of the heart using a treadmill to measure blood flow . a scan can only be performed if you have a small amount of radiopharma in your body . it is given into a vein by your hand . images
do not use rapiscan if you have slow heart rate , high degree heart block , sinus node disease ( when a pacemaker is not working well ), chest pain ( unstable angina ), or treatment of low blood pressure ( hypotension ) or heart failure if you are allergic to regadenoson . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents do not give this medicine to children under 6 years of age because it has not been studied in this age group . if any of the above applies to your child , tell your doctor or pharmacist before you
rapiscan will be given to you by a doctor or nurse who is experienced in the care of patients with a history of problems with your heart and blood pressure . the recommended dose is one injection into a vein ( 400 micrograms / ml ) of a 5 ml solution the injection will usually be given over a period of 5 to 10 minutes depending on your weight . your doctor may also give you an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( 5 ml / ml ). rapiscan contains a radioactive substance ( radiopharmaceutical ). your doctor will calculate the dose of rap
like all medicines , rapiscan can cause side effects , although not everybody gets them . most of the side effects are mild to moderate . however , some may be serious and require therapiscan injection lasting 30 minutes or longer . your doctor will decide whether you need any treatment . tell your doctor straight away if you notice any of the following side effects : sudden stopping of the heart which may be a sign of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak .
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated , and your doctor will tell you how long you should continue to take viagra as a treatment for adult men with erectile dysfunction ( impotence ). this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra if : you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain ") in adults . if you are not sure , talk to your doctor or pharmacist before taking the medicines . you are also taking nitric oxide donors such as amyl nitrite , which can also be a factor in the risk of an increase in yourblood pressure . if any of these
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg once a day . viagra film - coated tablets can be taken with or without food . if you take more viagra orodispersible tablets than you should take viagra with food . swallow the tablets whole with a glass of water . do not crush or chew the tablets . taking viagra at the same time each day will help you to get an erection . you may find it easier to take it when you are sexually stimulated . you should continue to take vi
like all medicines , this medicine can cause side effects , although not everybody gets them . some of the side effects may be serious . stop taking viagra and see a doctor straight away if you notice any of the following serious side effects : viagra may cause an allergic reaction ( may affect up to 1 in 100 people ). symptoms may include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . if you get chest pains , try to sit or lie down in a semi - sitting position . you may need to take nitrates to relieve your chest pain . prolonged and
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : : : treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinson '. it is also used to treat thesymptoms of moderate to severe primary restless legs syndrome in children and adolescents .
do not take sifrol : - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine , if you have or have had any medical conditions , including symptoms of kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa is not suitable for the treatment of dysk
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for the treatment of parkinson ' s disease is 3 tablets per day . during the first week , the usual starting dose is 1 tablet ( 0 . 088 mg ) once a day . this will be increased to a daily dose of 0 . 264 mg in the second week ( see section 1 ). your doctor may increase your dose to half of this dose when you start to feel better . your doctor will tell you how many tablets to take each day . the usual
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of the frequencies of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( likely to affect up to 1 in 100 people ) rare ( unlikely to affect 1 in 1 , 000 to 10 , 000 people ) not known ( frequency cannot be estimated from the available data ) if you have parkinson ' s disease , you may experience the following side effects : - dyskinesia ( abnormal , uncontrolled movements of the limbs ); - dizziness ; - nausea ( sickness ); -
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg or 0 . 35 mg , respectively ( 0 . 7 mg / 0 . 5 mg ). - the other ingredients are : tablet core : aminotransferase type a ( e1201 ); tablet coating : mannitol ( e421 ), maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate in the tablet core ; tablet coat : white to off - white , round , biconvex . what sif
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye in adults . it is used in adults to prevent allergic conditions from occurring in the eye . the allergic reaction may be severe and may be life - threatening . the most commonly reported signs of allergic conjunctiveitis are itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor straight away . you may feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children or adolescents below the age of 3 years because benzalkonium chloride is present in the blood ( see section 6 . this is because the safety and efficacy have not been established ). clinical trials have not yet been performed in this age group . if you have kidney or liver problems , your doctor may decide to reduce the dose of emad
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is 3 drops in your eye once a day . this medicine is for use in both eyes . use in children and adolescents ( 12 years of age and above ) the recommended starting dose is 1 drop in the affected eye each day ( see section 2 , " how to use emadine "). do not use more than one drop in each affected eye at the same time each day . it is important that you follow your doctor ' s instructions
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using the drops and tell your doctor straight away if you notice any of the following : common side effects ( may affect up to 10 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness not known ( frequency cannot be estimated from the available data ): uncommon side effects : ( may effect up to 1 in 100 people ): eye disorders such as abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneal staining and dry eye . general side effects include headache ,
keep this medicine out of the sight and reach of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . store below 25 . store in the original package in order to protect from moisture and infections .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose ( e464 ), purified water , hydrochloric acid , sodium hydroxide ( for acidity levels and ph levels ) and water for injections ( see section 2 ). what emADine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to reduce the number of seizures in epilepsy ) in adults and adolescents 16 years of age and older . it is used for the treatment of newly diagnosed epilepsy , a form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). the epilepsy is unique in that the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of your brain ( partial onset seizure with or without secondary generalisation ). levetiratam has been given to you by your doctor to treat : - together
you must not be given levetiracetam actavis : - if you are allergic ( e . g . pyrrolidone derivatives ) to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you should tell your doctor if you have or have had kidney problems . he or she will monitor you closely for any slow down in the growth or unexpected puberty development of your child . anti - epileptics should not be used in children and adolescents under the age of 18 years . le
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis should be taken once a day in the morning and once in the evening , at about the same time each day . monotherapy dose in adults and adolescents from 16 years of age and older : the usual starting dose is 1 , 000 mg twice a day . your doctor may increase your dose up to 3 times a day depending on how you respond to the medicine . the doctor will prescribe the strength that is right for you . if you have the impression that the effect of
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms with a rash on the face followed by an extended rash with a high temperature and increased levels of liver enzymes ( shown in blood tests ) and a decrease in a type of white blood
what levetiracetam actavis contains - the active substance is levetoracetam . each tablet of leveturacetamactavis 250 mg contains 250 mg levetiraacetam ( as besilate ). each tablet ( 500 mg film - coated tablets ) contains 500 mg of the besiline active substance . - the other ingredient ( s ) ( excipients ) ( e . g ., tablet core ) is lactose , water for injections ( see section 2 ), peanut or soya ( containing lactose ), maize starch , soybean puree , pineapple puree ( type a ), soy
the active substance umeclidinium bromide belongs to a group of bronchodilators . incruse ellipta is used to treat adults . this medicine is used for the treatment of chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in your lungs become blocked , leading to breathing difficulties . this causes difficulties in breathing due to tightening of the muscles in the lungs . your doctor has prescribed this medicine to reduce the tightening of these muscles in order to help control your breathing difficulties and reduce the effects of copd on your everyday life . ellipta
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - have asthma , as this medicine may increase the risk of asthma when used in combination with other inhaled products . if this applies to you , tell your doctor straight away . - have heart problems - have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). -
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation once a day . you should inhale this medicine every day for 24 hours at the same time each day . use incruse ellipta every day until your doctor tells you otherwise . if you do not feel better after 24 hours , use your quick - acting reliever inhaler ( such as salbutamol ). always use the inhaler provided in this leaflet to help you remember to use it . do not try to inhale incru
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may occur uncommonly ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects these may affect more than 1 in 10 people : faster heart beat painful and frequent urination . these may be signs of a urinary tract infection ( common cold infection of nose , throat cough , feeling of pressure , pain in the cheeks and forehead ). inflammation of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the sealed tray in the outer carton in order to protect from light . after first opening of the vial , the inseipta should be used within 6 months of first opening . once the seal has been removed from the refrigerator , do not store incruse ellipta above 30 . once you have removed the seal , use it immediately . do
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose of 55 micrograms ( 0 . 5 millilitres ) umclidium . each delivered dose provides a deliver dose of 65 microgramms ( 1 . 0 millilitre ) umedicinium Bromide . - the other ingredients ( excipients ) are lactose monohydrate ( see section 2 for further information on lactose '), magnesium stearate ( e470b ), and water for injections ( for inhalation use ). what incru
nucala contains the active substance mepolizumab , which is a monoclonal antibody . this is a type of protein that recognises and attaches to a specific target in the body . nucala is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( an important type of white blood cell that helps the airways to open ) and affects the lungs . in patients of all ages ( including those whose asthma is not being controlled with medicines called high dose inhalers ) it is important that you continue to use these medicines until
do not use nucala : if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have worsening asthma 58 you have experienced asthma - related side effects . your doctor may want to monitor your asthma more closely while you are using the medicine . if this applies to you , tell your doctor straight away . if you have any further questions on the use of this type ( monoclonal antibodies ), please ask your doctor or pharmacist . severe allergic reactions to other
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg given once a week ( 1 injection in the pre - filled pen ). if you have any further questions on the use of nucala , ask your doctor , pharmacist or nurse . duration of treatment your doctor will tell you how long you should continue to receive the treatment . your doctor may decide to reduce your dose or stop the treatment temporarily or permanently , depending on your asthma symptoms and on how you respond to injections . if you miss an appointment to go to the doctor ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) at the site of the injection . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you experience a reaction similar reaction to any of the other side effects listed above . very
keep this medicine out of the sight and reach of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pen in the outer carton in order to protect from light . after first opening , the pen may be stored for a single period of up to 7 days without being refrigerated again . after this period , the product should be used within 7 days .
what nucala contains - the active substance is mepolizumab . each ml of solution contains 1 mg of 100 mg ( international units ). - the other ingredients are aminotransferase , sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 ( e433 ), edta disodium dihydrate and water for injections . see section
what ninlaro is and what it is used for it is a cancer medicine that contains the active substance ixazomib ( also called a ' proteasome inhibitor '). what is it used for ? what is myeloma ? your doctor has prescribed this medicine for you because you have a cancer of the bone marrow called multiple sclerosis ( mds ) that has spread to other parts of the body . it is given to you when your doctor thinks that you may have a problem with your immune system ( the body ' s natural defences ). how does it work ? in mds , it helps to control cell survival
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . do not take any more of the following : if you think any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice before taking any other medicines . if you take more of these than you should if you accidentally take too much of one of these , tell your doctor straight away . stop taking the medicine and contact your doctor immediately if you
do not take ninlaro if you have multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you exactly how many capsules of this medicine to take . do not take more than one capsule of the same strength twice a day . if you cannot swallow the capsules whole , talk to your doctor , pharmacist or nurse before taking this medicine . how long to take the recommended dose is one capsule ( 0 . 5 mg ) of lenalidomide and dexamethasone once a day
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs orfeet ( peripheral oedema ) skin rash ( itchy all over the body ). rare side effects may affect up to 1 in 1 , 000 people : severe skin rashes , red to purple bumps ( sweet
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . the capsule can be removed from the blister and left at room temperature ( up to 30 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance in each capsule is ixazomib . each capsule contains 2 . 3 mg ixasomib citrate . the other ingredients are : capsule content : microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide ( e1520 ) and black iron oxide . the printing ink contains : - the capsule content is white to off - white , printed with ' ix ' on one side and ' 3
do not use palforzia if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor , pharmacist , or nurse before using palfORzia . use in children and adolescents ( from 4 to 17 years of age ) the safety and efficacy of treatment in children with peanut allergy has not been established in this age group . peanut ( desensitisation ) is not a treatment for children . do not give this medicine to children under the age of 18 years because there is no information on the safety of this medicine in children under 18 years . other medicines and p
do not take palforzia - if you are allergic to peanut or soya or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have severe asthma . your asthma is getting worse . you have a problem swallowing , especially if you have long term problems with your digestive system such as a severe mast cell disorder or severe or life - threatening anaphylaxis . it may take up to 60 days before you feel better . your doctor may decide to reduce the dose of your polozia
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been told by your doctor that you have allergy , allergic reactions ( anaphylaxis ) may occur within 3 months of starting treatment with palforzia . initial doseescalation and up - dosing steps you should follow the instructions of your doctor for these treatment steps . your doctor will instruct you on how to follow these steps . if necessary , your doctor may also instruct you to increase the initial dose elevation and subsequent doses . how much to take the recommended dose of palf
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions tell your doctor straight away if you have any of the following symptoms during treatment with this medicine : - signs of the reaction include trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting - severe stomach cramps , pain , vomiting , diarrhoea , severe flushing and itching of the skin . these could be signs of problems with the stomach and digestive system ( eosinophilic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store below 25 . store in the original package in order to protect from moisture . this medicine must not be used if you notice any hard lumps of powder or particles in the solution .
what palforzia contains the active substances are : 0 . 5 mg , 1 mg , 10 mg and 20 mg . the other ingredients are : microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfORzia 100 mg : oral powder in capsules with openingmicrocrystallose cellulose ( e460i ), colloidal Anhydroussilica ( e463 ) and magnesium unstearate ppforzias 300 mg : full - scale oral solution for injection in sachet microcrystine celluloses ( e462i), colloidalanhydrous
the active substance of zerene is benzodiazepine . it belongs to a group of medicinal products known as hypnotic actions . it is used to treat sleeping problems in adults . the duration of treatment is one month . your doctor will decide how long you should continue treatment . if you have problems sleeping , talk to your doctor .
you should not be given zerene : - if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have been diagnosed with a severe form of zerenea sleep apnoea syndrome ( which occurs for short periods ) you have severe kidney or liver problems you have myasthenia gravis ( which causes you to feel very weak , tired muscles , severe breathing or chest problems ) you are under 18 years of age .
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule per day to be taken orally with or without food . if you have difficulty falling asleep , you should take the capsule at least one hour before or one hour after food . use in elderly ( over 65 years ) patients with mild to moderate liver problems this dose may be increased to two 5 mg capsules per day depending on your response to treatment . if the capsule becomes cloudy , you may experience an overdose . you may also feel increasingly drowsy or have a
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ): very rare ( affects less than 1 users in 1 , 000 ) very rare : very rare rare : may affect up to 1 in 10 , 000 not known : frequency cannot been estimated from available data . very rare
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are : capsule contents : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate . capsule shell : lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( e171 ). printing ink : shellac , lecithin , simethicone ( e1520 ), yellow iron oxide ( e172 ). what zereNE looks like and contents of the pack zeren 5 mg is an intense dark blue powder with a light
